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CHAPTER I 
 
INTRODUCTION 
 
Microtubule Network 
The cell is a fundamental unit of life, and the building block of every living thing. 
The importance of the cell can be witnessed in every essential life process from 
development to death; however, this small feat of nature would not be possible were it 
not for the coordinated efforts of a variety of intracellular organelles and structures that 
help provide regulation of the cell. One of the key components of this regulation is the 
cytoskeleton. The eukaryotic cytoskeleton can be divided into three main components: 
actin, intermediate filaments, and microtubules (MTs). The focus of this section will be 
on MTs and their contribution to cellular function and architecture. 
 
    MTs are hollow, cylindrical structures composed of globular α/β-tubulin 
heterodimers that are capable of organizing into a 13-member protofilament with an 
overall diameter of 25nm. MT nucleation originates at the microtubule-organizing center 
(MTOC), where γ-tubulin associates with other proteins to form the γ-tubulin ring 
complex (γ-TURC) on which α/β-tubulin heterodimers polymerize. The γ-TURC also 
serves as a stable platform on the minus end of polymerizing MTs. The α/β-tubulin 
heterodimers impart an intrinsic polarity to the protofilaments by their head-to-tail 
assembly.  Consequently, this polarity can help define the two distinct ends of MTs: a 
fast-growing plus-end and a slow growing minus-end. MTs emanating from MTOCs play 
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specific roles in a variety of cellular events, which range from directional molecular 
transport, ciliary or flagellar motility, and chromosome segregation, to cytokinesis. The 
MT network also serves as an internal “highway system” in order to efficiently deliver 
cargos and organelles to distinct locations (Hirschberg et al., 1998; Musch, 2004). This 
movement along the MTs relies on molecular motors, which carry cargo along the MT 
(Sheetz, 1996; Hirokawa, 1998) and generate the force necessary to transport 
organelles(Hall et al., 1993). There are two classes of motors known to traffic along 
MTs: kinesins and dynein. While kinesins typically provide plus-end directed movement 
(Vale et al., 1985; Hall and Hedgecock, 1991; Cole et al., 1993), dynein provides minus-
end directed movement (Schnapp and Reese, 1989; Schroer et al., 1989).  Specifically, 
kinesin-dependent transport is essential for post-Golgi cargos to be transported to the 
cell periphery, while dynein-dependent transport is require for retrograde transport from 
cell periphery to cell center (Schnapp and Reese, 1989), ER-to-Golgi transport and 
proper Golgi organization (Burkhardt et al., 1997; Roghi and Allan, 1999). Perturbations 
to the MT network, such as through treatment with MT depolymerizing agent, 
nocodazole, leads to disorganized intracellular transport (Hirschberg et al., 1998). 
Therefore, it is crucial that an intact MT network be maintained for efficient delivery of 
intercellular signals that regulate the process of cell motility. 
 
    The ability of MTs to function in all of these processes relies on their ability to 
assume higher-order architecture in different subcellular compartments; however, just 
as these structures must be assembled, they must also be disassembled. This 
polymerization (assembly) and depolymerization (disassembly) cycle relies on the 
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hydrolysis of GTP to GDP (Weisenberg et al., 1976; Margolis, 1981; Carlier et al., 
1997), and potentially other factors. Both alpha and beta tubulin can bind GTP, but only 
hydrolysis of GTP on beta tubulin is thought to affect the polymerization or 
depolymerization state of MTs (Weisenberg et al., 1976). Hydrolysis of GTP on beta 
tubulin weakens monomer interaction with surrounding monomers, favoring a state of 
MT depolymerization and influencing the dynamic state of MTs (Arnal et al., 2000). As 
the rate of polymerization and the rate of GTP hydrolysis differ, this creates a GTP-
tubulin cap at the growing MT plus-end; however loss of this cap induces rapid 
depolymerization (Mitchison and Kirschner, 1984). It must be noted that, once MTs 
begin the process of polymerization, their growth can be regulated by a unique property 
known as dynamic instability. This property is characterized by periods of MT growth in 
the presence of a GTP tubulin cap and MT depolymerization when hydrolysis of GTP 
tubulin to GDP tubulin reaches the + tip of the MT (Kirschner and Mitchison, 1986). 
These distinct phases in MT dynamics are classified into three categories. The switch 
from MT growth to MT depolymerization is termed catastrophe. The switch from MT 
shrinking to MT growth is termed rescue. Lastly, the period of time that results between 
periods of growth and shrinking is termed pausing. 
 
The complete disassembly of MTs without appropriate cellular cues would lead to 
cellular deregulation. Dynamic instability leads to continual turnover of the MT network 
and is critical for the necessary remodeling of the MT network in response to the 
constantly changing cellular environment (Gundersen et al., 2004; Mattie et al., 2010). 
This is an important feature, as the MT network plays crucial roles in cellular 
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organization and dynamics in both mitotic and interphase cells. In mitotic cells, the MT 
network organizes into astral and kinetochore fiber subsets that are crucial for proper 
chromosome alignment and segregation during cell division. In motile interphase cells, 
the MT network organizes an asymmetric array that modulates delivery of cargos to 
distinct cellular domains (Sheetz, 1996; Small and Kaverina, 2003; Noritake et al., 2005; 
Watanabe et al., 2005). This ability of the MT network to assume an asymmetrical 
arrangement aids in the polarized remodeling of the actin cytoskeleton (Krendel et al., 
2002; Rodriguez et al., 2003; Bretscher, 2005; Siegrist and Doe, 2007), as well as 
facilitating efficient focal adhesion turnover at the leading and trailing edge of migrating 
cells (Chabin-Brion et al., 2001; Ezratty et al., 2005). Therefore, the ability of the MT 
network to be remodeled must be precisely regulated to prevent abrupt changes in 
cellular architecture or disruption in the spatiotemporal distribution of organelles and 
signaling molecules. 
 
Microtubule Associated Proteins (MAPs) 
    As the MT network comprises a large part of the eukaryotic cytoskeleton, subsets 
of proteins that are capable of interacting with tubulin have arisen. There are two major 
classes of microtubule-associated proteins (MAPs): structural MAPs and motor proteins. 
The term “structural MAPs” refers to the ability of these proteins to bind, stabilize, and 
promote the assembly of MTs. Prototypical members of this class of MAPs include: 
MAP1a, MAP1b, MAP4, Tau, and others, while motor proteins are represented by the 
two major classes, dynein and kinesins (Mandelkow and Mandelkow, 1995; Marx et al., 
2005).  
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    Structural MAPs typically have repeating domains, which allows for the 
interaction of the MAP with multiple tubulin dimers. This ability to interact with more than 
one dimer is thought to aid in the ability of the MAPs to influence polymerization rates of 
MTs. This interaction not only stabilizes the tubulin dimers, but also imparts stability by 
crosslinking several subunits at once.  The binding and unbinding of structural MAPs, 
however, must be tightly regulated to coordinate with multiple cellular processes. 
Structural MAPs are regulated by both kinases and phosphatases (Cassimeris and 
Spittle, 2001). In mitosis, for example, MAPs must be phosphorylated by kinases, such 
that they detach from the MT lattice; however, at the end of mitosis, these proteins must 
be dephosphorylated so that they regain the ability to interact with tubulin. Additionally, 
structural MAPs assist in motor transport by creating space around MTs (Chen et al., 
1992). Therefore, the ability of MTs to interact with associating proteins is necessary to 
regulate MT dynamics, as well as trafficking along the MT. 
     MT motor proteins are typically comprised of three domains: a head, a stalk, and 
a tail. It must be noted that the number of heads associated with a particular motor 
varies. Typically, the head region contains an ATP-binding site that allows for 
movement, in addition to the nucleotide-dependent MT-binding site.  The stalk region of 
motor proteins is mainly responsible for the flexibility and ability of the protein to homo-
dimerize. The tail region is responsible for interacting with specific cargo proteins 
(Stewart et al., 1991; Schnapp, 2003).  
    In addition to associating with the MT network and influencing the dynamics of 
MTs, MAPs can also have various other functions. For instance, RAS-Association 
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Domain Family 1A  (RASSF1A) can also function as a tumor suppressor and scaffold 
for apoptotic machinery. Additionally, MT-associated GEF-H1 can influence actin 
polymerization by interacting with Rho GTPases. MT association serves not only as a 
way to regulate these proteins, but also provides a scaffold on which they can exert 
their function. 
 
RASSF1A 
    Ras-association domain family member 1A (RASSF1A) is a MAP and tumor 
suppressor protein that was identified to associate with MTs via a yeast-2-hybrid 
screen. The interaction of RASSF1A with MTs is one of the mechanism by which 
RASSF1A is thought to exert its tumor suppressor function. Localization of RASSF1A 
with the MT network is thought to occur through some yet identified domain;  however, 
RASSF1A has been shown to bind tubulin in interphase and mitosis (Liu et al., 2003; 
Rong et al., 2004), as well as, MAP1b, C19ORF5, and MAP4 (Liu, 2002; Dallol et al., 
2004; Song et al., 2005). When bound to MTs, RASSF1A can promote MT stabilization 
(Liu et al., 2003; Dallol et al., 2004; Song et al., 2004; Vos et al., 2004), and potentially 
mediate MT polymerization by acting as a scaffold with interacting partners that promote 
tubulin assembly. Loss of RASSF1A either through phosphorylation or other methods 
has detrimental effects on MT stability as well as cell-cycle progression (Dallol et al., 
2004). Thus, RASSF1A expression must be tightly regulated to maintain a functional 
MT network capable of responding to changes in cellular cues.     
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    As mentioned above, RASSF1A is also a tumor suppressor protein that belongs 
to a family of RASSF proteins, of which there are eight total members, RAASF1-8. This 
family of proteins is so named due to the fact that they all contain Ras-association (RA) 
domains. However, the functionality of this domain among the different family members 
is quite varied, thus, its role in mediating biological effects remains unclear. The 
RASSF1 gene is located on chromosome 3p21.3 and contains eight exons. Through 
alternative splicing and differential promoter start sites, seven different transcriptional 
products can be made, RASSF1A-G (Dammann et al., 2000; Lerman and Minna, 2000; 
Burbee et al., 2001). The major splice variants from this region are RASSF1A and 
RASSF1C, both of which are ubiquitously expressed in normal tissues. Structurally, 
these two variants contain very similar domains. Both contain a C-terminal RalDDS/AF6 
Ras-association domain (RA) necessary for mediating interactions with Ras and other 
small GTPases(Ponting and Benjamin, 1996; Yamamoto et al., 1999) and a 
Sav/RASSF/Hpo (SARAH) domain that mediates protein-protein interactions important 
for cell-cycle exit and apoptosis (Scheel and Hofmann, 2003). Additionally, both proteins 
also contain an ataxia telagectasia mutant (ATM) domain, which may allow RASSF1A 
and RASSF1C to be a substrate for ATM (Kim et al., 1999). However, RASSF1A also 
contains an additional N-terminal diaglycerol/phorbol ester-binding (DAG) domain (or 
protein kinase C conserved region C1), which contains a zinc finger (Newton, 1995). 
Though structurally very similar, the activities and regulation of RASSF1A and 
RASSF1C during disease are quite different, frequently resulting in loss of RASSF1A, 
while retaining RASSF1C expression. 
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    Silencing of tumor suppressor genes by epigenetic modification is a fundamental 
inactivation mechanism of cancer-related genes in the pathogenesis of human cancer 
(Jones and Baylin, 2002). Particularly, promoter hypermethylation plays an essential 
role in loss of function of tumor suppressor genes (Herman and Baylin, 2003). Aberrant 
methylation of the RASSF1A promoter is found in over 40 types of sporadic human 
cancers (Burbee et al., 2001; Pfeifer and Dammann, 2005). Loss of RASSF1A 
expression is associated with increased spontaneous tumor formation (Tommasi et al., 
2005; van der Weyden et al., 2005): Likewise, ectopic expression in RASSF1A-null 
cancer cells lead to reduced anchorage independent growth, suppressed tumor cell 
growth, reduced invasiveness, and reduced tumorigenicity in vivo and in vitro 
(Dammann et al., 2000; Burbee et al., 2001; Dreijerink et al., 2001; Kuzmin et al., 2002; 
Chow et al., 2004; Hesson et al., 2004). Therefore, RASSF1A functions as a tumor 
suppressor, via regulation of the MT dynamics, that is required for proper cellular 
maintenance, particularly in the formation of cellular architecture and cell migration; 
however, many questions related to the biological function of RASSF1A, specifically in 
interphase, continue to remain unanswered. 
 
GEF-H1 and other Rho GEFs 
  The cytoskeleton, particularly MTs, provides a network on which many signaling 
and regulatory molecules localize; therefore, alterations to the cytoskeleton can cause 
changes in intracellular signaling events (Williamson et al., 1996; Jesuthasan and 
Stahle, 1997; Rowning et al., 1997). Localization of these and other proteins are 
capable of interacting with the MT network to facilitate a variety processes. GEF-H1 and 
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p190RhoGEF are both MAPs that are regulated by MTs. MTs regulate the activity of 
GEF-H1 and p190RhoGEF, through binding to the MT lattice. This binding effectively 
inactivates GEF-H1(Birkenfeld et al., 2008; Heck et al., 2012) and p190RhoGEF (van 
Horck et al., 2001), which prevents them from interacting with their respective Rho 
family members. MT depolymerization can release GEF-H1 and p190RhoGEF into the 
cytoplasm and allow them to interact with RhoA, facilitating actin polymerization. 
Therefore, Rho GEFs must be tightly regulated to prevent aberrant interaction with 
downstream targets. Deregulation of Rho GEF activity can lead to disease progression, 
particularly cancer. It has been shown that several oncogenes isolated by the NIH-3T3 
transformation assay are activated forms of Rho-GTPase (Cerione and Zheng, 1996). 
For example, several truncation mutations of GEF-H1 have been identified that 
abrogate MT binding, causing constitutive activation of GEF-H1 (Krendel et al., 2002), 
which can induce cellular transformation through promoting irregular RhoA cycling 
(Sahai and Marshall, 2002). Overall, this indicates that activation of GEF-H1 by 
eliminating MT-binding sequences can cause oncogenic transformation, thus their 
activity must be tightly controlled. Thus, the ability of MTs to regulate and activate these 
specific Rho GTPase family members through the action of MT-associated GEFs is 
quite important. Therefore, feedback mechanisms must exist to finely tune the activity of 
their effects on one another. 
 
Microtubules and Rho GTPases 
There has been a myriad of evidence that supports the idea that MTs are 
capable of regulating the Rho family of GTPases. Disruption of MTs leads to increased 
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vasoconstriction and agonist-induced contraction (Leite and Webb, 1998; Zhang et al., 
2001; Brum Cde et al., 2005). It is well established that the Rho/Rho kinase pathway is 
a mechanism by which contraction can occur in VSMCs (Fukata et al., 2001; Kawano et 
al., 2002; Katoh et al., 2011). Thus, the assembly state of MTs can affect Rho 
activation. The mechanism of this activation of the Rho kinase pathway is thought to 
occur via activation of specific Rho family members. Depolymerization of MTs activates 
RhoA (Liu et al., 1998; Chang et al., 2008; Takesono et al., 2010), which re-
polymerization can activate Rac1 (Waterman-Storer et al., 1999; Siegrist and Doe, 
2007).  
 
 Not only do MTs regulate Rho family members, but there is also evidence that 
Rho family members can influence MTs. Stabilization and MT rearrangement within the 
cell have both been shown to be a result of RhoA activation. Other Rho family 
members, such as Cdc42 and Rac1, can influence MT dynamics. This influence is 
exerted through the Pak1-mediated phosphorylation of stathmin, which is thought to 
promote MT growth; thus, a positive feedback loop is created whereby MTs at the 
leading edge activate Rac1. This Rac1, in turn, can inactivate stathmin and propagate 
MT growth and actin polymerization (Daub et al., 2001; Wittmann et al., 2003). This 
interplay between Rho-family members and MTs helps to create an asymmetrical MT 
network, which can facilitate polarization and directional cell migration; however, not 
only can RhoGTPases regulate MTs, but they are also capable of regulating the actin 
cytoskeleton, thereby impacting actin-dependent processes. 
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Actin regulation by Rho GTPases 
  Rho GTPases can also regulate the actin cytoskeleton by a well-characterized 
mechanism that supports cytoskeletal reorganization for many cellular processes. This 
family of small GTPases is found in all eukaryotes and has been shown to regulate actin 
dynamics. Rho proteins act as molecular switches that cycle between an inactive GDP-
bound state to an active GTP-bound state. As such, these proteins must be tightly 
regulated in order to prevent aberrant activation of their downstream effectors. This 
regulation occurs immediately after the addition of posttranslational modifications, such 
as farnesylation or geranylation, that position the inactive GTPase within the plasma 
membrane (Ridley, 2006). Inactivation is enhanced by the presence of Rho Guanine 
Dissociation Inhibitors (RhoGDIs), which interact with the isoprenyl GDP/GTP switch 
region of Rho GTPases and ultimately prevent their activation and translocation to 
target membranes (Hori et al., 1991; Michaelson et al., 2001). Signaling events, as well 
as dissociation factors, allow for release of Rho GTPases from RhoGDIs. Once Rho 
GTPases are released, they are able to interact with guanine nucleotide exchange 
factors (GEFs), which catalyze the exchange of GDP for GTP. This exchange activates 
Rho GTPases and allows them to interact with downstream effectors (Ridley et al., 
2003). Upon stimulus removal, Rho GTPases interact with GTPase activating proteins 
(GAPs), which hydrolyze GTP, and return the Rho GTP to its inactive state (Hori et al., 
1991). Rho GTPases play an important role in the formation of actin comet tails in this 
process, Rho GTPases, specifically Cdc42, activate N-WASP, which is then recruited to 
endosomal membranes (Bu et al., 2010). Activated N-WASP can recruit Arp2/3 to 
nucleate actin comets (Bu et al., 2010), thus serving as a propulsion force at the 
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endosomal membrane. Recently it was shown that RhoB is also involved in the 
formation of actin comets (Sandilands et al., 2004). RhoB activation facilitates actin 
comet formation by stimulation of two classes of actin polymerization machinery, 
formins (mDia1, mDia2) and Arp2/3. This stimulation has a functional consequence, as 
the induction of actin polymerization machinery can, in turn, provide the necessary force 
at vesicle membranes to propel them in the cytoplasm. 
 
Actin in vesicular trafficking 
  Actin is a highly conserved protein that is encoded by multiple genes within an 
organism. Like MTs, actin filaments exhibit a plus- to minus-end polarity, with higher 
monomer affinity at the plus end. Actin polymerizes as both a meshwork and as parallel 
bundles. These distinct actin networks are important for cell motility, either by forming 
lamellipodia or by providing the contractile force necessary to move the cell. The 
nucleation and subsequent polymerization of actin filaments is important to drive many 
cellular processes, including vesicular trafficking (Sandilands et al., 2004). Due to its 
dynamic properties, actin plays various roles in the transport of endocytic vesicles; first, 
actin may serve as tracks for motor-driven vesicular transport. Additionally, actin 
promotes tubule formation and vesicle fission. Moreover, actin polymerization can occur 
asymmetrically at the vesicle membrane to provide a pushing force in the form of actin 
comets. The best characterized mechanism for Arp2/3-dependent actin comet tail 
formation is in the bacterium Listeria monocytogenes, which utilize an Arp2/3 interacting 
protein, ActA, to hijack host actin polymerization machinery (Cameron et al., 1999). In 
eukaryotes, a similar mechanism of actin comet tail formation has been described as a 
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general mechanism by which endosomes are trafficked. Actin comet tail formation can 
also occur as a result of the activation of formins, mDia1 and mDia2 (Sandilands et al., 
2004). Activation of these formins localizes them to endosomal membranes where they 
can facilitate the polymerization of filamentous actin. This mechanism of formin-
mediated vesicle delivery is one of the currently accepted hypotheses on how the proto-
oncogene c-Src, whose localization and activity must be finely tuned to ensure proper 
signaling, is trafficked and positioned in cells. 
 
c-Src as a proto-oncogene 
  Src is a major proto-oncogene that is involved in a variety of human cancers. 
Though Src is rarely mutated in human cancers, it has been shown to exhibit elevated 
expression levels to elicit oncogenic transformation (Irby and Yeatman, 2000). Src 
activity and localization must be tightly regulated in order to prevent aberrant signaling. 
Src signaling is important for a variety of cellular processes, such as cell motility and 
regulation of endocytosis (Sanjay et al., 2001; Cao et al., 2010). Src contains six 
domains and can be regulated in a variety of ways. In the inactive state, C-terminal Src 
Kinase (CSK) phosphorylates Src at Tyrosine 527, allowing Src to assume a folded 
conformation, which prevents phosphorylation of Tyrosine 416 within the kinase 
domain. Activation of Src, either through direct binding of Focal Adhesion Kinase (FAK) 
or dephosphorylation of Tyrosine 527 by phosphatases PTP or SHP1/2, allows Src to 
assume an open conformation. This open conformation then allows for phosphorylation 
of Src in the kinase domain by PKC (Protein Kinase C), PKA (Protein Kinase A) and 
other kinases, thereby permitting Src to phosphorylate downstream targets. Disruption 
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of Src function has been shown to cause defects in cell motility and invasion. Src 
knockout mice exhibit defects in tooth eruption, reproductive organ development, 
osteopetrosis, and T-cell development (Roby et al., 2005).  
  
  Src has been shown to be transported within the cell in association with 
endosomal membranes (Horne et al., 1992; Kaplan et al., 1992; Reinecke et al., 2014). 
However, there are currently two opposing views as to how Src may be trafficked at 
these endosomal membranes. While Src-associated endosomes have been shown to 
be trafficked bidirectionally along MTs in neurons (Wu et al., 2008), another report 
showed that in fibroblasts Src-associated endosomes are trafficked by polymerizing 
actin, likely in the form of actin comet tails (Sandilands et al., 2004). The trafficking of 
Src-associated endosomes by actin polymerization relies on the small GTPase, RhoB. 
Nonetheless, the precise subcellular localization of Src via trafficking is critical for Src to 
perform its functions, such as in signaling (Donepudi and Resh, 2008), development 
(Berta et al., 2011), and in degradative podosome formation in osteoclasts and cancer 
cells (Berdeaux et al., 2004; Miyazaki et al., 2004; Boateng et al., 2012). The underlying 
mechanism required to precisely position c-Src within specific cellular domains 
continues to be a topic of debate, but it appears that contributions by both cytoskeletal 
networks are possible and may potentially coordinate to improve the efficiency of the c-
Src vesicle trafficking. 
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Mediating cytoskeletal crosstalk 
  MTs and actin exhibit two mechanistic classes of interactions, both regulatory 
and structural (Rodriguez et al., 2003). During cell polarization, MT depolymerization 
influences the polarity of actin filaments (Rodriguez et al., 2003). In addition, it has been 
shown in S. cerevisiae that capture of MT plus-ends by the EB1 ortholog, Bim1p, at the 
cell cortex by the Adenomatous Polyposis coli (APC) ortholog, Kar9p, is required for 
transport of MTs along actin filaments, their capturing at the cell cortex, and for 
organization of the MT cytoskeleton (Tirnauer et al., 1999). Another well-characterized 
mechanism of crosstalk involves the Rho family of small GTPases. Specifically, RhoA 
promotes both the formation of actin stress fibers and the stabilization of a subset of 
MTs, thus coordinating actin filaments and MTs (Imamura et al., 1998). Rac1, another 
RhoGTPase, has also been shown to regulate the polymerization of both actin and MTs 
(Guo et al., 2006). Coordination of the MT and actin networks is also regulated by the 
Rho Guanine Nucleotide Exchange Factor, GEF-H1 (Krendel et al., 2002), which 
catalyzes the exchange of GDP for GTP and the subsequent activation of Rho family 
class members, including RhoA and RhoB (Kamon et al., 2006; Birkenfeld et al., 2007; 
Chang et al., 2008). Binding to MTs inhibits GEF-H1 activity (Yoshimura and Miki, 
2011), but upon MT depolymerization, GEF-H1 assumes an active conformation, which 
allows it to interact with downstream targets (Yoshimura and Miki, 2011). Together, this 
indicates a clear connection between the cytoskeletal networks and a mutual regulation 
by Rho GTPases. 
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Thesis Summary 
  The work presented in this thesis follows years of investigation by other scientists 
into the mechanisms by which RASSF1A expression can be lost through promoter 
hypermethylation, as well as the overall effects on various cells types; however, the cell 
biological function of RASSF1A MT binding and the effects that its loss has on MT-
related processes in interphase cells has yet to be examined. Additionally, the work 
presented here is also the product of a long-standing debate about the true mechanism 
of c-Src trafficking within cells, specifically, which cytoskeletal elements and proteins are 
involved in the process. 
 
  In Chapter II, I highlight my efforts to efforts to determine the functional 
consequence of RASSF1A binding to MTs. Chapter II discusses how RASSF1A 
localizes to MTs, as well as how this binding influences MT stabilization and protection, 
MT dynamics, Golgi organization and maintenance, and cell migration. Chapter III 
presents a second project that focuses on solving the debate on the mechanism of c-
Src trafficking and identifying the molecular players involved. Overall, this thesis 
contributes to a better understanding of the functional significance of RASSF1A binding 
to MTs, in addition to, the resolution of the mechanisms involved for regulation of c-Src 
trafficking. 
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CHAPTER II 
 
Microtubule segment stabilization by RASSF1A is required for proper microtubule 
dynamics and Golgi integrity 
 
This chapter is published under the same title in Molecular Biology of the Cell, January, 
2014 (Arnette et al., 2014).  
 
Abstract 
The tumor suppressor and microtubule-associated protein, Ras-association 
domain family 1A (RASSF1A), has a major impact on many cellular processes, such as 
cell-cycle progression and apoptosis. RASSF1A expression is frequently silenced in 
cancer and is associated with increased metastasis. Therefore, we tested the 
hypothesis that RASSF1A regulates microtubule organization and dynamics in 
interphase cells, as well as the impact on Golgi integrity and cell polarity. Our results 
show that RASSF1A utilizes a unique microtubule-binding pattern to promote site-
specific microtubule rescues, and loss of RASSF1A led to decreased microtubule 
stability. Furthermore, RASSF1A-associated stable microtubule segments are 
necessary to prevent Golgi fragmentation and dispersal in cancer cells and maintain a 
polarized cell front. These results indicate that RASSF1A is a key regulator in the fine-
tuning of microtubule dynamics in interphase cells and proper Golgi organization and 
cell polarity.  
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Introduction 
Ras association domain family 1A (RASSF1A) is a tumor suppressor whose 
inactivation is thought to be responsible for 40 types of sporadic human cancers (van 
der Weyden and Adams, 2007). Recruitment of DNA methyltransferases to the 
RASSF1A promoter, and subsequent promoter hypermethylation, serves as the main 
mechanism of RASSF1A loss (Dammann et al., 2000; Burbee et al., 2001; Lee et al., 
2001). As RASSF1A lacks enzymatic function (Donninger et al., 2007), the currently 
accepted function is to serve as a scaffold for a number of essential signaling 
interactions (Donninger et al., 2007). Therefore, RASSF1A can participate in a variety of 
processes that regulate apoptosis (Vos et al., 2000; Baksh et al., 2005) and cell-cycle 
progress (Shivakumar et al., 2002), both of which likely impart the tumor suppressive 
function of RASSF1A by decreasing the cancer cell number. Besides the scaffolding 
function, RASSF1A also strongly binds microtubules (MTs) in vitro and in cells (Dallol et 
al., 2004). Such binding increases MT stability: in cells, RASSF1A overexpression 
induces MT hyper-stabilization, while RASSF1A depletion decreases MT resistance 
against depolymerizing drugs (Liu et al., 2003; Dallol et al., 2004). MT-binding ability of 
RASSF1A was proposed to be important for the mitotic spindle dynamics and cell cycle 
progression (Rong et al., 2004; Vos et al., 2004). Currently, it is clear that RASSF1A 
regulates cell cycle progression acting as an Aurora A-dependent scaffolding platform 
within a complex signaling mechanism (Rong et al., 2007). MT binding likely contributes 
to this mechanism via RASSF1A recruitment (Song et al., 2004; Rong et al., 2007), 
which may be important for the tumor suppressive function RASSF1A, as mutants 
deficient in MT binding were not as potent in cell-cycle arrest (Dallol et al., 2004). 
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However, there is no direct evidence for the importance of RASSF1A-dependent MT 
stabilization in mitosis-cell cycle regulation.  
 
Importantly, loss of RASSF1A expression in cancer cells is concomitant with the 
formation of a more invasive and metastatic cancer phenotype (Lee et al., 2001; Muller 
et al., 2003; Kang et al., 2004; Liu et al., 2005; Jo et al., 2006), which depends strongly 
on migratory rather than proliferative features of cancer cells. Indeed, RASSF1A 
depletion was shown to facilitate HeLa cell migration in vitro (Dallol et al., 2005). It has 
been hypothesized that the ability of RASSF1A to bind MTs is responsible for this 
phenotype (Dallol et al., 2004), which would have been a justified function for 
RASSF1A-dependent MT stabilization. Indeed, RASSF1A depletion affects the overall 
MT pattern(Dallol et al., 2005); however, the origin of this change has not been 
addressed, and whether and how RASSF1A regulates MT dynamic instability in motile 
cells is unknown. 
 
Here, we applied high-resolution confocal and TIRF microscopy to determine 
RASSF1A-dependent MT regulation in motile cells in detail. Because the function of 
known MT-binding proteins depends on their specific localization and dynamics within 
the MT network, we also investigated cellular localization of RASSF1A and potentially 
associated functions. We determined that RASSF1A binds to MTs in a distinct 
segmental pattern and exerts its MT-stabilizing effect only within these segments. Such 
site-specific MT stabilization increases MT rescue frequency specifically at the 
RASSF1A-coated MT segments. RASSF1A-associated MT segments serve as sites for 
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temporal bundling of short regions within MTs, which probably contributes to MT 
network organization. We also found that RASSF1A-associated MT segments are 
necessary for the Golgi complex integrity and positioning, which is a known essential 
determinant for polarized cell migration (Kupfer et al., 1983; Miller et al., 2009; Yadav et 
al., 2009). This study provides the first evidence of the role of MT-bound RASSF1A in 
MT dynamic instability regulation and the architecture of interphase cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   21	  
Results 
RASSF1A localizes at discrete MT segments 
 The goal of this study was to investigate functions for RASSF1A in interphase cells 
and to determine whether loss of these functions is essential for phenotypes of cancer 
cell in which RASSF1A is silenced. To address this, we utilized two cells systems, 
including normal Retinal Pigment Epithelial cell (RPE1) and the epithelial breast cancer 
cell line, MCF-7. To determine RASSF1A localization and dynamics, GFP- or RFP-
fused RASSF1A was ectopically expressed in both cell types, and expression levels 
were examined by immunoblotting. We found that endogenous expression of RASSF1A 
was low in RPE1, and, as previously reported (Kellokumpu et al., 2002), completely 
absent in MCF-7. Since high expression of RASSF1A is known to over-stabilize MTs 
(Liu et al., 2003; Dallol et al., 2004; Rong et al., 2004; Vos et al., 2004), ectopic 
expression of fluorescently-fused RASSF1A in cells used for our experiments was 
maintained at near or slightly less than endogenous levels (Figure 2.1 A). Under these 
conditions, RASSF1A was detected as short linear segments (Figure 2.1 B’, B’’’). 
Because previous reports have shown that ectopically expressed RASSF1A can bind to 
the MT lattice (Rong et al., 2004), co-localization of these segments with MTs was 
tested by alpha-tubulin immunostaining of RFP-RASSF1A-expressing cells. We found 
that RASSF1A was localized linearly along the lattice of distinct MTs, highlighting a 
segmental pattern within the MT network (Figure 2.1 B-B’’’, left cell); however, when 
RFP-RASSF1A was overexpressed, this segmental pattern within the MT network was 
lost and MT bundling occurred (Figure 2.1 B, right cell).  We hypothesize that this 
unusual binding pattern may impart an important function for MT organization.  
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Figure 1: RASSF1A binds to the non-dynamic portion of MTs. 
 
(A) Western blot analysis of endogenous RASSF1A (Lanes 1,2) and expressed RFP-
RASSF1A (Lanes 3,4) in RPE1 and MCF-7 cells. (B) RPE1 cells expressing RFP-
RASSF1A (red) fixed and stained for tubulin (green). Immunostaining. Bar, 5µm. (B’-B’’’) 
RFP-RASSF1A (white arrowheads) localizes segmentally along MTs (yellow arrow) 
shown in (B). Bar, 2µm. (C) Detection of GFP-RASSF1A (green) and mCherry-EB3 
(red) in time-lapse TIRFM movie of a MCF-7 cell (5s/frame). Maximum intensity 
projection of four frames from mCherry-EB3 channel illustrates polymerizing MT plus 
end (C”). Bar, 5µm. (C’-C’’’) GFP-RASSF1A does not colocalize with mCherry-EB3 at 
the tip of MTs shown in C. Bar, 2µm.  
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Binding of RASS1A locally stabilizes MT segments 
Because localization of dynamic versus stable MTs defines the configuration of 
trafficking paths within a cell, and thus, is tightly connected with MT function, we 
addressed whether RASSF1A locally stabilizes MT segments. To determine whether 
RASSF1A-associated MT segments were dynamic, we applied live-cell total internal 
reflection fluorescence (TIRF) imaging of cells co-expressing GFP-RASSF1A and a MT 
plus-tip marker, mCherry-EB3. Polymerizing MTs, detected by tracking of EB3 comets, 
were devoid of RASSF1A. In many cases, RASSF1A was found at the non-dynamic 
portions of MTs, away from the plus ends undergoing dynamic instability (Figure 2.1 C-
C’’’). 
 
These data suggest that RASSF1A associates with specific, non-dynamic 
regions of dynamic MTs away from the polymerizing plus ends. To test whether binding 
of RASSF1A extends lifetimes of distinct regions of MTs, we addressed if these MT 
portions were post-translationally modified.  As detyrosination (Glu Tubulin) is an 
established marker for long-lived MTs, we first tested for this PTM by immunostaining in 
RPE1 cells transiently expressing variable levels of RFP-RASSF1A. Non-transfected 
cells exhibited low Glu tubulin levels (Figure 2.2 A-D). We detected enhanced levels of 
Glu tubulin in cells expressing RFP-RASSF1A (Figure 2.2 E-G’’, D), where these levels 
correlated with the level of RASSF1A expression (Figure 2.2 D). On a single MT level, 
Glu-tubulin was either co-localized with RASSF1A, or accumulated at MT regions 
flanked by RASSF1A-coated segments (Figure 2.2 G’-G’’), indicating that RASSF1A 
facilitated tubulin detyrosination indirectly by increasing MT lifetimes. We also found that 
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RASSF1A-associated MTs were often acetylated, though tubulin acetylation did not 
correlate with RASSF1A expression (not shown), indicating that though over-stabilized 
MTs accumulate tubulin acetylation (Piperno et al., 1987; Westermann and Weber, 
2003), other molecules are likely responsible for specific MT acetylation in cells. To 
examine whether RASSF1A-associated MT regions were indeed stabilized against 
depolymerization, RPE1 cells expressing RFP-RASSF1A and 3x-GFP-EMTB 
(ensconsin MT binding domain (Faire et al., 1999; Tanaka et al., 2009)), were subjected 
to the MT-depolymerizing agent, nocodazole. Confocal live-cell imaging revealed that 
MT depolymerization proceeds up to the point where RASSF1A is associated with the 
MT (Figure 2.2 H-J), indicating that RASSF1A locally protects the MT from further 
depolymerization. Thus, RASSF1A-coated MT segments might serve to regulate site-
specific MT dynamics.  
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Figure 2.2:  RASSF1A binding stabilizes and protects MTs from depolymerization.  
 
(A-C) Non-transfected RPE1 cell does not exhibit detyrosinated (green) MTs in the 
absence of RFP-RASSF1A  (red) expression. Immunostaining. (D) Intensity of 
detyrosinated (Glu) tubulin as correlated with RFP-RASSF1A expression. 
Representative examples out of 20 cells/condition. Error bars indicate s.e.m. (E-G) 
RFP-RASSF1A expression induces MT stabilization in RPE1 cells as detected by anti-
detyrosinated (Glu) tubulin staining. Immunostaining. Bar, 5µm. (G’-G’’) RFP-RASSF1A 
(red; white arrowheads) flanks portions of stable MTs as detected by anti-detyrosinated 
(Glu) tubulin staining shown in G. Immunostaining. Bar, 2µm. (H and J) Video frames of 
RFP-RASSF1A (red) and 3x-GFP-EMTB (green) expressing cells representing pre- and 
post-nocodazole treatment. Spinning-disk confocal (5s/frames). (I) Time sequences pre- 
and post-nocodazole addition illustrates RFP-RASSF1A (white arrow) MT protection 
capacity. Bar, 5µm. (K-O) RFP-RASSF1A (red; white arrowhead) expression in RPE1 
cells can function as sites of MT rescue, as detected by EB3-GFP labeled growing MT 
plus-ends (green; yellow arrow). Spinning-disk confocal (5s/frames). Bar, 5µm.  
 
 
 
 
	   28	  
RASSF1A localization defines sites of MT rescues 
 As RASSF1A binds segmentally to the MT lattice, one can infer that the segment 
borders provide distinct points of stabilization, which could serve as platforms for 
switching of MTs from depolymerization to polymerization (MT rescues). The location 
and persistence of rescue sites at interphase MTs, which continuously undergo dynamic 
instability, is crucial for MT network configuration. However, although RASSF1A has 
been implicated in influencing MT dynamics in mitosis (Vos et al., 2004), the direct 
effects of RASSF1A on MT dynamics in interphase have not been addressed.  To 
investigate the potential involvement of RASSF1A in regulating interphase MT 
dynamics, steady state analysis of RPE1 cells co-expressing low levels of RFP-
RASSF1A and EB3-GFP was performed. Cells were imaged with a spinning-disk 
confocal microscope to monitor the plus ends of growing MTs. RASSF1A-associated 
MTs acted as platforms for polymerizing MTs (Figure 2.2 K-O), which suggests that 
these sites can serve as points of rescue. To analyze the role of endogenous RASSF1A 
in overall MT dynamics parameters, peripheral MT dynamics were analyzed in H1792 
cells, a non-small cell lung carcinoma cell line, either expressing endogenous RASSF1A 
or shRNA depleted of RASSF1A (Figure 2.3 A) (Vos et al., 2006) by TIRF microscopy. 
Loss of RASSF1A via shRNA knockdown resulted in alterations in MT organization as 
compared to RASSF1A expressing cells (Figure 2.3 B-C). Consistent with our model, 
we found that the number of rescue events (Figure 2.3 D) and pause duration (Figure 
2.3 E) per MT was significantly decreased by RASSF1A depletion, indicating that this 
protein indeed functions as a rescue factor by stabilizing MT segments. Additionally, our 
analyses revealed that RASSF1A depletion led to an increase of MT polymerization and 
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depolymerization rates (Figure 2.3 G-H), as well as catastrophes per MT (Figure 2.3F). 
Such enhancement of MT dynamicity could be a manifestation of a lack of short-term 
pauses and rescues and is characteristic for depletion of a rescue factor (Mimori-
Kiyosue et al., 2005; Drabek et al., 2006). Collectively, these alterations in dynamics 
strongly decreased MT lifetimes after RASSF1A depletion (Figure 2.3 I-J).  
 Taken together, our data suggests a critical role for RASSF1A in fine tuning 
interphase MT network dynamics.  
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Figure 2.3: RASSF1A depletion influences MT dynamics. 
 
(A) Western blot analysis of RASSF1A in vector expressing (Lane 1) and RASSF1A 
shRNA depleted (Lane 2) H1792 cells. (B-C) H1792 cells expressing vector (B) or 
RASSF1A shRNA depleted (C) fixed and immunostained for tubulin. Immunostaining. 
Bar, 5µm. (D-J) Analysis of various MT dynamics parameters in H1792 RASSF1A 
shRNA depleted cells, reveals an increase in MT dynamicity. p-value < .05. Error bars 
indicate s.e.m. (I-J), Examples of MT life history plots in control H1792 cells and cells 
depleted of RASSF1A. Plots reveal decreased MT lifetimes upon RASSF1A depletion. 
Representative examples out of 20 cells/condition.
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RASSF1A bundles neighboring MTs 
 Because RASSF1A-associated MT segments clearly bear a specialized function in 
local MT behavior, we next addressed their positioning and integration within the whole 
MT network. We hypothesized that if RASSF1A were stably bound to MTs, addition of 
nocodazole would not increase cytoplasmic RFP-RASSF1A levels. Confocal live-cell 
imaging under these conditions revealed no appreciable increase in cytoplasmic RFP-
RASSF1A levels, and instead RFP-RASSF1A remained associated with MT fragments 
(compare a pre-nocodazole cytoplasmic fluorescence intensity of 176952 a.u. to a post-
nocodazole intensity of 183031 a.u., no significance). FRAP analysis also revealed that 
RFP-RASS1A is non-dynamic, suggesting that it is stably associated with a MT (Figure 
2.S1). Further analysis of live-cell imaging sequences showed that RASSF1A could 
promote bundling of pre-existing steady-state MTs (Figure 2.4 A-B’’’; 2.S2). MT bundling 
often resulted in a change in MT directionality from random to parallel, and coincided 
with the formation of thin MT bundles. Fluorescence intensity analysis of 3x-GFP-EMTB 
labeled MTs revealed that on average there is a three-fold increase in EMTB signal for 
RASSF1A-associated segments as compared to single MTs not bound by RASSF1A 
(Figure 2.4 C), suggesting that RASSF1A can bundle up to three MTs. Quantification of 
non-RASSF1A-associated MT bundling events in 1.5µm2 squares (similar to the size of 
RASSF1A segments), and RASSF1A-associated MTs revealed that the majority of 
RASSF1A-coated MT segments facilitate bundling within the MT network (Figure 2.4 D). 
Additionally, quantification of non-RASSF1A-associated MT unbundling reveals a 
significantly higher number of unbundling events as compared to RASSF1A-associated 
MTs (Figure 2.4 E). Thus, RASSF1A stabilizes MT-MT interactions, which could provide 
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a significant influence in altering the MT network configuration. These properties can be 
used for specific MT functions required at distinct cellular locations. For example, 
centrally located RASSF1A-associated segments may facilitate reliable Golgi complex 
assembly (Ryan et al., 2012) by maintaining the Golgi complex integrity (Cole et al., 
1996).  
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Figure 2.4: RASSF1A is transported with MTs and induces local bundling to alter 
MT network configuration. 
 
(A and B) RPE1 cells expressing RFP-RASSF1A and 3X-GFP-EMTB. Area in box is 
enlarged to the right. Spinning-disk confocal. Bar, 5µm (A’-A’’’ and B’-B’’’) RFP-
RASSF1A (yellow arrow) locally bundles neighboring MTs (white arrow). Bar, 2µm. (C) 
Analysis of fluorescence intensity in single versus RASSF1A-associated MTs reveals 
RASSF1A can bundle at least 3 MTs at one time. Representative examples out of 15 
cells/condition. Error bars indicate s.e.m. (D) Average number of bundling events per 
1.5µm2 reveals a significant increase in these events with RASSF1A-associated MTs as 
compared to non-RASSF1A-associated MTs. (E) Average number of unbundling events 
per 1.5µm2 reveals a significant decrease in unbundling events in RASSF1A-associated 
MTs as compared with non-RASSF1A-associated MTs. Representative examples out of 
10 cells.
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RASSF1A-associated MT segments are required for Golgi integrity 
 Analysis of the cellular localization of RASSF1A-associated MT segments 
revealed that they were accumulated predominantly in the central cell region. Co-
staining with a Golgi marker, GM130, revealed the close proximity of these segments 
with the Golgi apparatus (Figure 2.5 A-C). Such specific localization may indicate that 
MTs in the Golgi area possess higher RASSF1A-binding properties; for example, 
because a cofactor needed for this segmental binding is enriched at the Golgi 
membrane or in the perinuclear region (e.g. the nuclear transport regulator small 
GTPase Ran, which was identified as a possible cofactor for MT binding of RASSF1A 
(Dallol et al., 2004; Dallol et al., 2009).) Another attractive possibility is that such 
localization reflects specific functions of RASSF1A-associated MTs in Golgi 
organization or positioning. We hypothesize that RASSF1A localization at the Golgi 
suggests a functional relationship whereby RASSF1A-induced MT stabilization provides 
a scaffold for Golgi assembly. Indeed, in MCF-7 breast cancers cells, which lack 
endogenous expression of RASSF1A, Golgi stacks are dispersed throughout the cell 
(Kellokumpu et al., 2002), (Figure 5 D-F, M). To determine the role of RASSF1A in 
Golgi positioning, we examined the effects of altering RASSF1A protein levels on the 
cellular distribution of the Golgi, visualized by GM130 immunostaining. First, we utilized 
re-expression of RFP-RASSF1A in MCF-7 cells at low levels, which we consider close 
to physiological expression in non-cancerous cells (Figure 2.1 A). Interestingly, we 
found that under these low-expression conditions, the typically dispersed Golgi 
fragments were collected to the cell center (Figure 2.5 G-I, M), and the number of Golgi 
fragments was significantly reduced as compared to non-transfected cells (Figure 2.5N). 
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However, when RFP-RASSF1A was over-expressed at high levels in MCF-7 cells, 
resulting in coating of the entire MT network, the Golgi became redistributed throughout 
the cell, resembling non-transfected controls (Figure 2.5 J-L, M). This result suggests 
that low levels of RASSF1A, when it functions to stabilizes discrete MT segments, are 
necessary for proper Golgi assembly. To further test this hypothesis, we addressed if 
RASSF1A depletion in non-cancerous cells also affects Golgi structure. In RPE1 cells 
treated with either siRNA against human RASSF1A or with control scrambled siRNA 
(Figure 2.5 O), we determined the effect of RASSF1A depletion on Golgi structure by 
examining individual cells stained with GM130. In scramble control cells, the Golgi 
showed a compact morphology (Figure 2.5 P). In contrast, RASSF1A-depleted cells 
showed aberrant Golgi features, including fragmentation of the Golgi (Figure 2.5 Q-S). 
Interestingly, the level of Golgi fragmentation in RASSF1A siRNA depleted RPE1 cells 
was similar to levels observed in non-transfected or RFP-RASSF1A overexpressing 
MCF-7 cells (Figure 2.5 N, T). Therefore, we conclude that centrally located RASSF1A 
is essential for proper Golgi complex organization.  
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Figure 2.5: RASSF1A expression alters Golgi morphology. 
 
(A-C) MCF-7 cell expressing low levels of RFP-RASSF1A, fixed and stained for Golgi 
protein, GM130 (green). Immunostaining. RFP-RASSF1A localizes at MTs associated 
with the Golgi and at the cell periphery. (D-L) MCF-7 cells expressing various levels of 
RFP-RASSF1A (red) and immunostained for Golgi protein, GM130 (green). (D-F) Non-
transfected MCF-7 cell exhibits a dispersed and fragmented Golgi. (G-I) MCF-7 cell 
expressing low levels of RFP-RASSF1A exhibits a compact Golgi. (J-L) MCF-7 cell 
overexpressing RFP-RASSF1A exhibits a dispersed and fragmented Golgi. Bar, 5µm. 
(M) Analysis of Golgi dispersal under various conditions of RFP-RASSF1A expression. 
Representative examples out of 10 cells/condition. (N) Analysis of Golgi fragmentation 
in non-transfected and low RFP-RASSF1A expressing MCF-7 cells. Representative 
examples out of 10 cells/condition.  (O) Western blot analysis of RASSF1A siRNA 
depletion in RPE1 cells. Lane 1, Non-targeted (NT) RASSF1A siRNA; Lanes 2-4, 
RASSF1A siRNA combinations. (P-S) RPE1 cells treated with RASSF1A siRNA and 
immunostained for Golgi protein, GM130. (T) Analysis of Golgi fragmentation in RPE1 
cells after RASSF1A siRNA depletion. Bar, 5µm. (L,M.T). Representative examples out 
of 10 cells/condition.  Error bars indicate s.e.m.  
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RASSF1A-depletion disrupts cell polarity and migration 
 As loss of RASSF1A alters MT dynamics and Golgi organization, one can 
hypothesize that this loss would also impact cell migration. Previous reports have 
identified that RASSF1A overexpression can suppress cell migration (Dallol et al., 2005; 
Jung et al., 2013); however, the ability of low levels of RASSF1A expression to 
influence directionality of cell migration or polarization of migrating cells, has yet to be 
examined. To address the effect on directional persistence of migration, control or 
RASSF1A-depleted RPE1 cells were examined by differential interference contrast 
(DIC) microscopy and were subjected to persistence analysis. Depletion of RASSF1A 
significantly decreased the directional persistence of RPE1 cells (Figure 2.6 A-C), 
indicating that RASSF1A, likely through modulation of Golgi integrity, promotes 
persistent migration. Cell polarity has been analyzed assessing direction of cell 
protrusions formed throughout a time sequence. Area taken by all the protrusions was 
combined, and the circularity of the resulting shape was quantified. In this analysis, if 
protrusions were formed equally around the cell perimeter (lack of polarity), the overlaid 
protrusion area formed a donut shape (circularity equals one). If protrusions form only at 
one side of a cell (high polarity), the overlaid area is significantly asymmetric (circularity 
approaches zero).  This analysis reveals a significant increase in protrusion circularity 
when cells were depleted of RASSF1A (Figure 2.6 D-I, J). MCF-7 cells also exhibited 
high measures of protrusion circularity similar to siRNA RASSF1A-depleted RPE1 cells 
(Figure 2.6 K-M, Q). Re-expression of RFP-RASSF1A in MCF-7 cells significantly 
reduced the protrusion circularity (Figure 2.6 N-P, Q; Figure 2.S3), but was unable to 
completely restore polarity in these cells, which may require additional molecular 
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players, which are inactive in these immobile cells. Additionally, re-expression of RFP-
RASSF1A did not appear to influence the overall migratory ability of MCF-7 cells. 
Furthermore, upon re-expression of RFP-RASSF1A in MD-MBA-231 cells, a highly 
motile cell type, polarity was restored to levels seen in control RPE1 cells (Figure 2.6 R-
W, X; Figure 2.S3) and these cells exhibited increased directional persistence (Figure 
2.6 Y-A’). Thus, these data suggest that the variation in RASSF1A regulation of cell 
polarity may greatly depend on the inherent motile capacity within cells types. 
Collectively, these data suggest that RASSF1A regulation of cell polarity can potentially 
occur through modulation of Golgi integrity and organization, as well as via regulation of 
MT dynamics. 
 
 
 
 
 
 
 
 
 
 
 
	   42	  
	   43	  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: RASSF1A expression and depletion disrupts directional persistence 
and cell polarity.  
 
(A-B) Representative migration tracks from control and RASSF1A-depleted RPE1. (C) 
Analysis of directional persistence in control and RASSF1A depleted RPE1 cells reveals 
that depleted cells fail to migrate directionally and exhibit more random movement. 
Representative examples out of 10 cells/condition.  (D-I) RASSF1A-depleted RPE1 
cells demonstrate a lack of polarity as compared with control RPE1. (J) Analysis of 
protrusion circularity in control and RASSF1A-depleted RPE1 cells. Representative 
examples out of 12 cells/condition. (K-P) Re-expression of RFP-RASSF1A in MCF-7 
cells partially rescues cell polarity defects. (Q) Analysis of protrusion circularity in control 
and RFP-RASSF1A expressing MCF-7 cells. Representative examples out of 12 
cells/condition. (R-W) Re-expression of RFP-RASSF1A in MD-MBA-231 cells 
significantly reduces the protrusion circularity. (X) Analysis of protrusion circularity in 
control and RFP-RASSF1A expressing MD-MBA-231. Representative examples out of 
12 cells/condition. (Y-Z) Migration tracks from control and RFP-RASSF1A expressing 
MD-MBA-231 cells indicate an increase in directional persistence upon RASSF1A re-
expression. (A’) Analysis of directional persistence in MD-MBA-231 cells. 
Representative examples out of 12 cells/condition.
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Discussion 
  
 In this study, we detected segmental binding of RASSF1A to MTs, which is an 
unusual pattern for a MT-associated protein. The mechanism whereby RASSSF1A 
accumulates at selected regions of the MT lattice may be a consequence of cooperative 
binding of RASSF1A molecules to a MT. Indeed, previously described ability of 
RASSF1A for self-association (Ortiz-Vega et al., 2002), as well as for 
heterodimerization with other RASSF family members (Ortiz-Vega et al., 2002; 
Praskova et al., 2004; Guo et al., 2007) may promote the cooperative binding. 
Alternatively, a preferred RASSF1A-binding area may exist within an MT, either due to 
accumulation of a RASSF1A-binding MT-associated protein (e.g. MAP1B (Dallol et al., 
2005)), or if modification of tubulin within the MT lattice favors association with 
RASSF1A. The latter possibility is less likely as indicated by our data (Figure 2.2). Any 
of these mechanisms likely leads to a high concentration of RASSF1A molecules on the 
MT lattice. Thus, these short regions of MT length likely exhibit properties similar to 
extremely stable MTs previously described in cells overexpressing RASSF1A (Liu et al., 
2003; van der Weyden et al., 2005). On one hand, the capacity to stabilize MTs as the 
result of MT lattice-binding proteins is very common; many MT-associated proteins 
(MAPs), such as neuronal Tau (Tanaka et al., 2009) or MAP2 (Takemura et al., 1992) 
and MAP4 (Nguyen et al., 1997) stabilize MTs to build long, reliable tracks for MT-
dependent transport. On the other hand, the unusual segmental pattern observed with 
RASSF1A-driven stabilization of short MT portions provides a mechanism for 
distinguishing two contrasting dynamic behaviors within one MT, and serves to regulate 
site-specific MT dynamics. 
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 Furthermore, our data on MT bundling indicate that massive MT bundling 
previously observed upon RASSF1A over-expression (Liu et al., 2003; El-Kalla et al., 
2010) is not a random artifact but an exaggerated manifestation of a bona fide function. 
This evidence places RASSF1A within a subset of MAPs that contain MT bundling 
abilities (e.g. PRC1 (Mollinari et al., 2002), Synapsin I (Baines and Bennett, 1986). Such 
properties likely indicate that RASSF1A is capable of remodeling the interphase MT 
network via local bundling and connection of short fragments among two or three MTs.  
RASSF1A-associated segments found close to the cell periphery, which can be 
revealed by TIRF microscopy (and thus proximal to the ventral cell surface), might be 
involved in the formation of bundled MT arrays, which may serve for directional post-
Golgi trafficking towards the cell front in motile cells (Rahkila et al., 1997; Schmoranzer 
and Simon, 2003; Lee et al., 2009).  
 
 At the same time, we show that centrally located RASSF1A-associated segments 
facilitate Golgi complex assembly and integrity. We hypothesize that RASSF1A defines 
the sites of preferred Golgi interaction with MTs, and that association of RASSF1A with 
MT fragments in the cell center promotes Golgi stack fusion and Golgi complex integrity. 
In this scenario, extending RASSF1A association over the whole MT network results in 
scattering of these sites throughout the cell. The connection between the Golgi and MTs 
may be mediated either directly through RASSF1A (or some yet unidentified linker 
protein) binding to the Golgi components, or through creating MT sites capable of 
stronger molecular motor binding. Alternatively, it is also possible that RASSF1A affects 
Golgi organization indirectly via MT stabilization specifically within the Golgi region, 
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providing a long-lived platform for Golgi assembly, or by facilitation of molecular motor 
binding (Cai et al., 2009). Furthermore, it was previously proposed that acetylation, a 
robust tubulin PTM found within the Golgi region, is important for MT-dependent Golgi 
assembly (Thyberg and Moskalewski, 1993; Ryan et al., 2012). MT acetylation may 
contribute to a RASSF1A-dependent mechanism of Golgi assembly, but is not likely to 
be the whole mechanism because tubulin acetylation was found, in many cases, to be 
independent of RASSF1A binding to MTs (data not shown). Ultimately, we can infer that 
a disruption in the Golgi structure, by loss of RASSF1A, specifically interferes with other 
MT-dependent processes at the Golgi, such as post-Golgi trafficking.  
  
 Additionally, we show that loss of RASSF1A leads to defects in cell migration and 
polarity; re-expression of RASSF1A can partially rescue polarization defects. We 
hypothesize that loss of RASSF1A at the Golgi significantly compromises the integrity 
and organization of the Golgi structure, both of which are required for directional cell 
migration and polarization (Bershadsky and Futerman, 1994; Yadav et al., 2009). With 
this idea, loss of RASSF1A would lead to scattering of Golgi membranes throughout the 
cell and the inability to form a single protrusion, potentially due to lack of directed 
secretion (Yadav et al., 2009). Moreover, lack of the bundling capacity exerted by 
RASSF1A may fail to provide the necessary stable MT tracks needed to establish a 
polarized front (Manneville et al., 2010; Chen et al., 2013). Alternatively, or additionally, 
RASSF1A-mediated regulation of cell migration and polarity may be a result of altered 
MT dynamics and organization. Ultimately, we can infer that perturbations to RASSF1A 
levels can result in significant changes in cell morphology and behavior 
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 Collectively, our results strongly suggest a role for RASSF1A in influencing 
interphase MT dynamics and Golgi positioning (Figure 2.7 A). These functions probably 
contribute to prevent such cancer phenotype features as disorganized cell migration, 
which was shown to arise from the loss of RASSF1A (Dallol et al., 2005).  In particular, 
precise spatial regulation of MT dynamics in migrating cells is necessary for 
maintenance of persistent lamella at the cells front (Waterman-Storer et al., 1999), 
contact inhibition of migration (Kadir et al., 2011) and asymmetric focal adhesion 
turnover (Kaverina et al., 1999). Moreover, an integral polarized Golgi complex in the 
cell center is necessary for directional post-Golgi-trafficking to the cell front and 
directional cell migration (Yadav et al., 2009). Our finding allows us to hypothesize that 
an established dependence of directional cell migration on RASSF1A arises from the 
spatial regulation of the MT network and Golgi organization by RASSF1A-associated 
MT segments (Figure 2.7 B) 
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Figure 2.7: Models of RASSF1A contribution to MT functions and Golgi 
organization 
 
(A) Model of RASSF1A functions in interphase cells. (B) Model of the role of 
RASSF1A in directional cell migration. 
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Supplementary Materials 
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Figure 2.S1: RASSF1A is non-dynamic on MTs, related to Figure 2.4. 
 
(A-B) HeLa GFP-Tubulin expressing cell transfected with RFP-RASSF1A pre- and post-
bleach. White box indicates FRAP region. Bar, 5µm. (C) FRAP analysis of indicated 
region in B reveals that RFP-RASSF1A does not recover on MTs (spinning disk 
confocal,30s/frames.
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Figure 2.S2: RASSF1A expression alters MT network configuration, related to 
Figure 2.4. 
 
(A-C) MCF-7 cell fixed and stained for Tubulin (green). Immunostaining. Cells exhibit a 
radial MT network configuration. (D-F) MCF-7 cell expressing low-levels of RFP-
RASSF1A fixed and stained for Tubulin (green). Immunostaining. MT network 
organization is altered so that cells exhibit a more polarized morphology. (G-I) MCF-7 
cell overexpressing RFP-RASSF1A fixed and stained for Tubulin (green). 
Immunostaining. MT network is highly bundled as compared with C and F. Bar, 5µm.
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Figure 2.S3: RFP-RASSF1A expression in MCF-7 and MD-MBA-231 cells, related 
to Fig 2.6.  
 
(A-B) Representative images of RFP-RASSF1A cell transfection in MCF-7 and MD-
MBA-231 used for protrusion circularity and directional persistence analysis in Figure 
2.6, N and U. Bar, 10 µm.
	   56	  
Methods 
Cells 
 Immortalized human retinal pigment epithelial cells, hTert-RPE1 (Clontech), were 
maintained in DMEM/F12 with 10% fetal bovine serum (FBS). H1792 human tumor cell 
[24] lines were grown in RPMI with 10% fetal calf serum. MCF-7 breast cancer cells 
(American Type Culture Collection, Manassas, VA) and HeLa GFP-Tubulin (a kind gift 
of Paul Chang, MIT) were grown in DMEM with 10% fetal bovine serum. Cells were 
grown in 5% CO2 at 37°C. Cells were plated on fibronectin-coated glass coverslips 24 
hours before experiments. In all live cell experiments, cells were maintained on the 
microscope stage at 37°C under mineral oil for media equilibrium maintenance. 
 
Treatments 
 For MT depolymerization during live-cell imaging, cells were initially imaged in 
media lacking nocodazole (Sigma, St. Louis, MO). In the subsequent frames, the media 
was aspirated off and replaced with cell culture media containing nocodazole (2.5µg/ml) 
while imaging. 
 
shRNA, siRNA and Expression Constructs 
 RASSF1A shRNA has previously been described in [24]. Single or a combination 
of single Stealth siRNA oligos against RASSF1A (HSS174151, HSS117377; Life 
Technologies, Invitrogen, Darmstadt, Germany) were transfected into RPE1 cells using 
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Lipofectamine RNAiMax (Invitrogen, Carlsbad, CA) according to the manufacturer's 
protocol. RASSF1HSS174151 siRNA targeted sequence: 5’-
GGGACGCCUUCAGCAUGCCUGAACU-3’; RASSFHSS117377 siRNA targeted 
sequence: 5’-ACGCACAAGGGCACGUGAAGUCAUU-3’. Experiments were conducted 
72 hours post-transfection as at this time minimal protein levels were detected. Non-
targeting siRNA (Dharmacon, Thermo Scientific, Pittsburgh, PA) was used for controls. 
GFP-RASSF1A and RFP-RASSF1A have been described previously in [12] and [2], 
respectively. mCherry-EB3 (gift from J.V. Small, Vienna, Austria), EGFP-EB3 (gift from 
A. Akhmanova, Utrecht, The Netherlands) and 3x-GFP-EMTB (gift from J.C. Bulinski, 
New York, NY) were used for MT plus tip and MT visualization. RPE1 and MCF-7 cells 
were transfected with Fugene6 (Roche, Indianapolis, IN) according to manufacturer's 
protocols. 
 
Antibodies and Immunofluorescence Details 
 For Golgi identification, mouse monoclonal antibody against GM130 (1:300; BD 
Transduction Laboratories, San Jose, CA) was used. MTs were stained with anti-α-
tubulin rabbit polyclonal antibody (1:1000; Abcam, Cambridge, MA). For detyrosinated 
tubulin detection, a rabbit polyclonal antibody was used (1:500; Millipore, Billerica, MA). 
For MT and Golgi staining, cells were fixed (15' at room temp.) in 4% paraformaldehyde, 
0.025% Glutaraldehyde, 0.3% Triton in cytoskeleton buffer (10 mM MES, 150 mM 
NaCL, 5 mM EGTA, 5 mM glucose, and 5 mM MgCL2, pH 6.1). Alexa488-conjugated 
highly cross-absorbed goat anti-mouse IgG antibodies and Alexa488-conjugated goat 
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anti-rabbit IgG antibodies (1:500; Molecular Probes, Invitrogen, Eugene, OR) were used 
as secondary antibodies. 
Confocal and live cell imaging 
 Leica TCS SP5 confocal laser scanning microscope with an HCX PL APO 100x oil 
lens NA 1.47 was used for taking confocal stacks of fixed cells and photo-bleaching of 
living cells. 
 
 TIRFM live-cell videos were acquired on a Nikon TE2000E microscope with Nikon 
TIRF2 System using a TIRFM 100x 1.49 NA oil lens, and Cascade 512B camera 
(Photometrics) and IPLab software (Scanalytics). 
 
 Live cells plated on MatTek glass bottom dishes were maintained at 37°C by 
heated stage (Warner Instruments). Single plane confocal video sequences were taken 
were taken by Yokogawa QLC-100/CSU-10 spinning-disk head (Visitec assembled by 
Vashaw) attached to Nikon TE2000E microscope using CFI PLAN APO VC 100X OIL 
lens, NA 1.4 with 1.5× intermediate magnification and back-illuminated EM-CCD 
camera Cascade 512B (Photometrics) driven by IPLab software (Scanalytics). 75 mW 
488/568 Krypton-Argon laser (Melles Griot) with AOTF was used for 2-color excitation. 
Custom double dichroic mirror and filters (Chroma) in a filter wheel (Ludl) were used in 
the emission light path.  
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Western blot analysis 
 Western blotting was performed with the Protein Electrophoresis and Western 
Blotting System (Bio-Rad, Hercules, CA). For western blotting, a mouse polyclonal 
antibody against actin (1:1000; pan-Ab-5; Thermo Scientific, Pittsburgh, PA) and a 
mouse anti-human antibody against RASSF1A (1:500; EBioscience, San Diego, CA), 
were used. Nitrocellulose membrane was incubated with primary and then secondary 
antibody (LI-COR Bioscience, IRDye™ 800 and 700, Lincoln, NE) diluted in Odyssey 
Blocking Buffer with 0.2% Tween-20 to lower background. Odyssey Infrared Imaging 
System (LI-COR Bioscience, Lincoln, NE) was used for membrane scanning. 
 
FRAP 
 FRAP was performed using Leica TCS SP5 confocal laser scanning microscope. 
ROI were introduced in cells expressing GFP-Tubulin and RFP-RASSF1A within RFP-
RASSF1A segments. Photo-bleaching of said ROIs was carried out with 100 percent 
laser power of the 561 laser. Cells were then imaged for 15 minutes with 30-second 
intervals to monitor RFP-RASSF1A recovery. 
 
Quantitative analyses: 
MT Dynamics Parameters 
 To analyze MT dynamic parameters in NT control cells and RASSF1A-depleted 
cells, 5 min single channel TIRFM sequences (3 sec/frame) of cells expressing 3x-GFP-
EMTB were used. Individual MTs were manually tracked using the MTrackJ plugin of 
ImageJ by following movements of the MT tip as visualized by 3x-GFP-EMTB 
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expression. Cells expressing low levels of 3x-GFP-EMTB were used to avoid analysis of 
cells with dampened MT dynamics. 20 MTs per condition (NT control or RASSF1A-
depleted) were analyzed. Average number of events (rescue, catastrophe, pause and 
pause duration) were manually calculated per MT; This was then used to calculate the 
frequency (rescue and catastrophe) per MT/min. Average MT growth and shrinkage rate 
was calculated from instantaneous velocity measurements obtained from the MTrackJ 
plugin of ImageJ.  
 
Distance Dispersal 
 Distance dispersal analysis was first performed with ImageJ. Golgi particles were 
subjected to thresholding and X, Y coordinates obtained using the Analyze Particles 
function of ImageJ. X, Y coordinates were then analyzed using a custom program 
written in MATLAB to calculate average distance between all particles. 
 
Golgi Fragmentation 
 Golgi fragmentation analysis was performed with the Analyze Particles function of 
ImageJ. Golgi particles were subjected to thresholding and the number of particles was 
automatically calculated. 
 
Fluorescence Intensity 
 Intensity in cells expressing various levels of RFP-RASSF1A was measured using 
ImageJ software. Cells of interest were outlined with a selection tool and measurements 
were set (Area, integrated density, and mean gray value). Three background 
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measurements were taken. To correct for background, the following formula was used: 
Corrected Total Cell Fluorescence = Integrated Density – (Area x Mean Fluorescence of 
Background Readings). Similar methods were used to determine fluorescence intensity 
of RFP-RASSF1A associated MTs and single, non-associated MTs. 
 
Bundling and unbundling 
 Bundling analysis of non-RASSF1A-associated MTs was restricted to 1.5µm2 ROIs 
(similar to the size of RASSF1A segments). The total number of ROIs analyzed was 
equal to the total number of RASSF1A segments in the cell. Bundling and unbundling 
events were quantified as those lasting two frames (10s) or more. Events per ROI were 
divided by the total number of MTs within the ROI to determine the “per MT” contribution 
to bundling (or unbundling). RASSF1A-associated MTs were quantified per RASSF1A 
fragment. 
 
Cell Polarity 
 To analyze cell polarity, 6-hour DIC sequences (180s/frame) of cells depleted 
(RPE1) or expressing (MCF-7 and MD-MBA-231) RASSF1A were used. Cell polarity 
was analyzed by assessing the direction of cell protrusions formed throughout the time 
sequence. The initial area of the cell (Frame 1) was subtracted from the combined area 
taken by all protrusions in subsequent frames. The circularity of the resulting shape was 
quantified by ImageJ Circularity analysis. In this analysis, if protrusions were formed 
equally around the cell perimeter (lack of polarity), the overlaid protrusion area formed a 
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donut shape (circularity equals one). If protrusions form only at one side of a cell (high 
polarity), the overlaid area is significantly asymmetric (circularity approaches zero).   
 
 
Statistical Analysis 
 Statistical significance was determined by Students t-test (two-tailed, unpaired). 
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CHAPTER III 
 
Microtubule and Actin interplay drive intracellular c-Src trafficking in VSMCs 
Abstract 
The proto-oncogene c-Src is a non-receptor tyrosine kinase that is involved in a 
variety of signaling processes that can regulate cell migration, adhesion, cell division, 
and survival in both normal and cancer cells. c-Src is rarely mutated during cancer 
transformation, but instead exhibits elevated expression levels in a variety of cancers. 
Therefore, c-Src localization must be tightly regulated to prevent aberrant 
phosphorylation of downstream targets; however, the true mechanism of c-Src 
trafficking is unclear. Thus, we tested the hypothesis that regulation of c-Src trafficking 
requires cytoskeletal crosstalk between microtubules and actin, which is mediated by 
GEF-H1 and RhoB. Our results show that c-Src vesicles move bidirectionally along 
microtubules; however, microtubule depolymerization leads to faster, but less directional 
c-Src vesicle trafficking, in addition to increased actin comet formation at c-Src vesicle 
membranes. Moreover, microtubule depolymerization also increased RhoB activation. 
Furthermore, loss of GEF-H1 activity significantly impaired actin comet tail formation 
and RhoB activation. These results indicate that c-Src trafficking is tightly regulated 
process that requires the coordinated efforts of both major cytoskeletal elements for 
efficient delivery to the plasma membrane. 
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Introduction 
c-Src is a non-receptor tyrosine kinase that has been implicated in pathways 
regulating angiogenesis, invasion and metastasis, cell migration, endocytosis, and 
many others. When inactive, c-Src is associated with the plasma membrane through an 
N-terminal fatty acid moiety. However, during activation, c-Src is released so that it can 
translocate to interact with its effectors (Bjorge et al., 2000). As such, when c-Src 
becomes deregulated, the effects can manifest in the processes that c-Src regulates, 
leading to several hallmarks of cancer(Hanahan and Weinberg, 2000; Yeatman, 2004). 
Frequently, increased c-Src expression and activity is associated with many 
malignancies, strongly suggesting a role for c-Src in oncogenesis (Alvarez et al., 2006); 
However, despite the increasing evidence for the role of c-Src in cancer transformation, 
c-Src alone is incapable of transforming human cells in vitro, and very few transforming 
mutations have been identified in human cancers(Shalloway et al., 1984; Irby et al., 
1999). Furthermore, during atherosclerotic plaque formation, vascular smooth muscle 
cells (VSMCs) assume a synthetic phenotype, whereby they become highly migratory 
and invasive. This process is mediated by the formation of invasive structures, 
podosomes, which are dependent upon c-Src localization to the plasma membrane. 
Therefore, since c-Src is involved in so many processes, the subcellular localization of 
c-Src is critical to its function (Biscardi et al., 1999). 
Currently, the mechanism by which c-Src is positioned within the cell is under 
debate. Whether the local positioning of c-Src within the cell is a MT-dependent, actin-
dependent, or some combinatorial mechanism has yet to be identified. Although 
evidence for the first two scenarios exists, they do not completely reconcile the 
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discrepancies found throughout the literature. Studies have indicated that inactive c-Src 
can be localized to the perinuclear region, colocalizing with endosomal and Golgi 
markers (Kaplan et al., 1992), and upon activation, it can be subsequently targeted to 
the cell periphery (Timpson et al., 2001). However, at present, the mechanism by which 
c-Src is localized in response to cellular cues is still quite not understood. In neuronal 
growth cones, trafficking of endosomal c-Src was identified as a MT-dependent process 
that allowed for bidirectional trafficking along the MT network (Wu et al., 2008). 
Depolymerization of MTs lead to an accumulation of plasma membrane-associated c-
Src, indicating a dependence on MTs, and not other cytoskeletal elements, for c-Src 
vesicle recycling in growth cones. Conversely, c-Src endosomal trafficking has also 
been identified as an actin-dependent process.  c-Src was found to mainly associate 
with RhoB-containing cytoplasmic endosomes which also contained actin nucleating 
machinery, specifically Scar1/WAVE1 and mDia2 (Sandilands et al., 2004). 
Here, we applied high-resolution confocal microscopy and biochemical 
techniques to determine the mechanism of c-Src trafficking, as well as the activation 
status of the molecular players involved. We determined that c-Src is trafficked 
bidirectionally along MTs; however, MT depolymerization does not inhibit c-Src vesicle 
movement, but instead, leads to faster, less directional movement. Furthermore, MT 
depolymerization resulted in increased actin comet tail formation at c-Src vesicle 
membranes. Regulation of these actin comet tails was found to be dependent on MT-
associated GEF, GEF-H1. Inhibition of GEF-H1 activity or constitutive activation 
resulted in decreased actin comet tails or actin comet tail formation similar to 
nocodazole-treated controls, respectively. Additionally, we also found that RhoB was 
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also trafficked bidirectionally along MTs and associated with a subset of c-Src vesicles. 
Moreover, MT depolymerization also lead to increased RhoB activation in these cells. 
This study provides the first evidence of the coordinated efforts of the MT and actin 
cytoskeleton in correctly trafficking c-Src from the perinuclear region to the cell 
periphery.  
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Results 
c-Src traffics bidirectionally on MTs 
The goal of this study was to investigate the molecular mechanism by which c-
Src is trafficked and whether this trafficking required the cooperative action of both the 
MT and actin cytoskeleton. To address this, we utilized a cell culture system including 
Retinal Pigment Epithelial cells (RPE1) and rat aortic vascular smooth muscle cells 
(VSMCs). Because previous reports have shown that c-Src can be trafficked 
independently by both MTs (MTs) (Wu et al., 2008), we first determined whether this 
mechanism existed in our system. We found that GFP-Src on endosomal membranes 
was trafficked bidirectionally along MTs (Figure 3.1 A-A’’’’’’) from the cell center and cell 
periphery. Depolymerization of MTs by the MT-depolymerizing drug, nocodazole, did 
not inhibit GFP-Src trafficking, but instead disrupted the trajectory of GFP-Src vesicles, 
restricting them spatially within the cytoplasm (Figure 3.1 B, C). Analysis of GFP-Src 
vesicle velocity under control and nocodazole-treated conditions revealed that upon MT 
depolymerization, GFP-Src vesicle velocity significantly increased (Figure 3.1 D). 
Additionally, analysis of vesicle directionality under these conditions reveals that vesicle 
movement becomes highly randomized as compared to control (Figure 3.1 E). We 
hypothesize that the continued movement of c-Src vesicles upon MT depolymerization 
may represent a secondary, but less efficient mechanism by which c-Src may be 
trafficked or may represent a part of a larger mechanism of c-Src trafficking whereby 
MTs provide long-range, directional trafficking and this secondary mechanism provides 
short-range delivery to the plasma membrane. 
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Figure 3.1: c-Src exhibits bimodal trafficking  
 
(A) Detection of GFP-Src (green) and 3x-mCherry-EMTB (red) in time-lapse confocal 
movie of an A7r5 cell. Area in box is enlarged to the right. Bar, 5µm. (A’-A’’’’’’) Imaging 
sequence illustrates that GFP-Src is trafficked bidirectionally along MTs in A. Bar, 2µm 
(B) GFP-Src vesicles exhibit long, directional movement in time-lapse confocal movie of 
an A7r5 control (5s/frames). Representative tracks. Bar, 5µm. (C) GFP-Src vesicles 
exhibit short, randomized movement in time-lapse confocal movie of an A7r5 control 
(5s/frames). Representative tracks.  Bar 5µm. (D) GFP-Src vesicles exhibit increased 
velocity in response to MT depolymerization. (D) GFP-Src vesicles show reduced 
directional persistence following nocodazole treatment.
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MT depolymerization induces actin comet tail formation through regulating  
GEF-H1  
Previous reports have demonstrated that c-Src trafficking may also be mediated 
through the action of actin nucleating machinery, particularly adaptor protein 
Scar1/Wave1 and actin filament regulatory protein, mdDia2 (Sandilands et al., 2004). 
To determine whether actin polymerization was the driving force behind c-Src vesicular 
movement upon MT depolymerization, we applied live-cell confocal microscopy imaging 
of cells co-expressing GFP-Src and RFP-cortactin, a marker of polymerizing actin. 
Additionally, we coupled this with immunofluorescence techniques to provide an overall 
idea of the magnitude of actin polymerization occurring. In both cases, we found that 
upon MT depolymerization, the number of actin comets formed significantly increased 
(Figure 3.2 A-C). Not surprisingly, we also found that association of cortactin puncta 
with c-Src vesicles was also increased upon MT depolymerization (Figure 3.2 D-F) 
 
These data suggest that MT regulation of some factor is perturbed upon MT 
depolymerization, allowing said factor to interact with actin nucleating machinery. As 
GEF-H1, a Rho GEFs regulated by MT binding (Krendel et al., 2002), has been 
implicated in being a mediator of cytoskeletal crosstalk (Birkenfeld et al., 2007; Chang 
et al., 2008), we examined whether it was involved in potentiating the formation of actin 
comet tails upon MT depolymerization. Utilizing cortactin as a marker of actin comet tail 
formation, we tested for formation by immunostaining in VSMCs transiently expressing 
various GFP-GEF-H1 constructs. GFP-GEF-H1-wild type (GEF-WT) expressing cells 
exhibited few actin comet tails prior to MT depolymerization, but this significantly 
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increased after treatment with nocodazole (Figure 3.2 G, K and J). In cells expressing 
GFP-GEF-H1-dominant negative (GEF-DN), actin comet tail formation was inhibited 
both in control and nocodazole treated cells (Figure 3.2 H, L, and J), further implicating 
GEF-H1 in mediating cytoskeletal crosstalk in our cells. Furthermore, cells expressing 
GFP-GEF-H1-constitutively active (GEF-CA) exhibited increased actin comet tail 
formation in the presence and absence of MTs, similar to levels seen in nocodazole-
treated control (Figure 3.2 I, M, and J). Thus, actin comet tail formation at c-Src vesicle 
membranes, through the action of GEF-H1, might serve as a secondary mechanism to 
increase the efficiency of c-Src trafficking. 
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Figure 3.2: GEF-H1 regulates formation of actin comet tails at c-Src vesicle 
membranes 
 
(A-B) Control and nocodazole-treated A7r5 cells fixed and stained for cortactin (green). 
Immunostaining. Bar, 5µm. (C) Quantification of actin comet tail formation in control and 
nocodazole-treated cells reveals a two-fold increase upon MT depolymerization. 
Representative examples out of 30 cells/condition. Error bars indicate s.e.m. (D-E) Live-
cell imaging of control and nocodazole-treated A7r5 cells expressing GFP-Src and  
RFP-Cortactin. Area in box is enlarged below. Bar 5µm. (F) Quantification reveals that 
MT depolymerization induces increased actin comet formation at c-Src vesicle 
membranes. (G and K) Z-section of A7r5 cells expressing wild-type GEF-H1 pre- and 
post-nocodazole fixed and immunostained for cortactin. Images illustrate an increase in 
cortactin puncta (white arrows) following MT depolymerization Bar, 5µm. (H and L) Z-
section of A7r5 cells expressing dominant-negative GEF-H1 pre- and post-nocodazole 
demonstrates the role of GEF-H1 in forming actin comets. Bar, 5µm. (I and M) Z-section 
of A7r5 cells expressing constitutively active GEF-H1 pre- and post-nocodazole show 
high number of actin comets in the presence or absence of MTs. Bar, 5µm. (J) 
Quantification of actin comet tail formation after expression of various GEF-H1 
constructs. Representative examples out of 30 cells/condition. Error bars indicate s.e.m. 
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RhoB associates with c-Src vesicle membranes 
 It has previously been identified that actin-dependent trafficking of c-Src vesicles 
relied on RhoB localization at the vesicle membrane (Sandilands et al., 2004). 
Moreover, actin nucleating machinery, Scar1/Wave1 and mDia2, were also shown to be 
required for efficient trafficking of c-Src to the cell periphery(Sandilands et al., 2004). 
However, as c-Src was shown to traffic by MTs (Wu et al., 2008), we tested whether 
RhoB-associated vesicles could also be trafficked in a similar manner. We utilized live-
cell confocal imaging of cells expressing GFP-RhoB and 3x-mCherry-EMTB and 
tracked vesicle movement. Our data shows that GFP-RhoB vesicles could traffic 
bidirectionally along MTs (Figure 3.3 A-A’’’) in a manner similar to c-Src vesicles. We 
hypothesize that the localization of RhoB vesicles on MTs is important for association 
with c-Src vesicles and may facilitate actin polymerization at c-Src vesicle membranes. 
To address whether c-Src and RhoB localized within the same vesicle, cells expressing 
GFP-RhoB and mCherry-Src were imaged by spinning-disk confocal microscopy. Our 
data shows that GFP-RhoB colocalized with a subset of mCherry-Src vesicles (Figure 
3.3 B-B’’’ and C) particularly at one side of the vesicle membrane. Positioning of RhoB 
at c-Src vesicles membranes may serve as a mechanism by which actin polymerization 
can be precisely localized and quickly initiated at c-Src vesicles. Localized positioning of 
RhoB at one site on c-Src vesicle membranes may facilitate asymmetric actin 
polymerization. Therefore, this localization potentially increases the efficiency of c-Src 
trafficking by sequestering components necessary to provide force at c-Src vesicle 
membranes.  
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Figure 3.3: RhoB is trafficked along MTs and associates with c-Src vesicles 
 
(A) A7r5 cells expressing GFP-RhoB (green) and 3X-mCherry-EMTB (red). Area in box 
is enlarged to the right. Spinning disk confocal. Bar, 5µm. (A’ – A’’’’) Time-lapse 
confocal microscopy reveals vesicles GFP-RhoB move along MTs (yellow and white 
arrows).  Bar, 2µm. (B) A7r5 cell expressing GFP-RhoB (green) and mCherry-Src (red). 
Area in box is enlarged to the right. Spinning disk confocal. Bar, 5µm. (B’ – B’’) Time-
lapse confocal microscopy shows that GFP-RhoB (yellow arrows) can associate with a 
subset of mcherry-Src vesicles (white arrows). (C) Mander’s coefficient distribution 
reveals that the majority of GFP-RhoB vesicles are associated with mCherry-Src.
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RhoB is activated by MT depolymerization 
 Prior reports have indicated that actin-dependent trafficking of c-Src vesicles 
relies on the activity of Rho GTPase, RhoB (Sandilands et al., 2004). Additionally, it has 
been shown that Rho GEF, GEF-H1, can interact with an activate RhoB to elicit actin 
polymerization (Kamon et al., 2006; Vega et al., 2012).  Because MT depolymerization 
clearly imparts a specialized trafficking ability of c-Src vesicles by actin comet tails, we 
next addressed their formation through activation of Rho GTPase, RhoB. We 
hypothesized that MT depolymerization can allow GEF-H1 to interact with and activate 
downstream effector RhoB for the formation of actin comet tails. To assess RhoB 
activation in the absence or presence of MT depolymerization, RBD-RhoB pulldowns 
were performed and immunoblotted for activated Rho. Analysis revealed that upon MT 
depolymerization RhoB exhibited a 15%-30% increase in their RhoB activity (Figure 3.4 
A and B). Thus, RhoB activity can be modulated by the presence or absence of an 
intact MT network. This regulation of RhoB activity may be even more significant out at 
the cell periphery, as the ability of MTs to undergo dynamic instability could fine-tune 
the final step in delivery of c-Src vesicle to the plasma membrane through localized 
release of GEF-H1 and RhoB activation, thus initiating actin polymerization. 
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Figure 3.4: RhoB is activated by MT depolymerization 
 
(A) Western blot analysis of RhoB activation in response to MT depolymerization in 
control and nocodazole-treated RPE1 cells. (B) Quantification of average percent of 
RhoB activation from A reveals that RhoB activation is significantly higher following MT 
depolymerization. (C) Model of cytoskeletal crosstalk for c-Src delivery.
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Discussion 
 In this study, we have sought to define a molecular pathway for trafficking of proto-
oncogene, c-Src, in addition to resolving a longstanding debate on the involvement of 
the MT and actin cytoskeletons. We have found that c-Src can be trafficked 
bidirectionally along MTs; however, in the absence of MTs, actin comet tail formation at 
c-Src vesicle membranes could provide the necessary force to mediate c-Src vesicle 
movement. This bimodal mechanism of trafficking may represent two distinct 
mechanisms that have converged to increase the efficiency of c-Src vesicle trafficking. 
Alternatively, this may also represent one singular, combinatorial mechanism. In the 
latter, actin polymerization at c-Src vesicular membranes would provide the force 
necessary to propel vesicles along MT tracks. Then, upon MT depolymerization, further 
facilitate the process of c-Src trafficking in a faster, less directional manner. Limited 
imaging capabilities have hindered the ability to test this hypothesis, however, it seems 
high unlikely as we know that this process of actin comet tails formation seems to be 
greatly influenced by the activity of GEF-H1, which would be inactive through binding to 
intact MTs near the perinuclear regions where c-Src has been found to accumulate in 
an inactive state (Radziwill et al., 2007; Walker et al., 2007). Conversely, it may also be 
possible that some yet unidentified Rho GEF could potentiate this combinatorial 
process. Though the idea of cytoskeletal crosstalk is a well-studied phenomenon, 
particularly in the context of identifying molecules that mediate this crosstalk; the 
functional consequence of lack of one or both of these cytoskeletal elements on 
vesicular trafficking or the processes they regulate has not been as well defined. 
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 Furthermore, our data suggests that the switch from MT to actin-based motility is 
mediated by the activity of GEF-H1, and that inhibition of GEF-H1 activity severely 
impairs the ability of actin comet tail formation. This evidence places GEF-H1 within the 
molecular pathway that defines the mechanism of c-Src trafficking. Though evidence for 
GEF-H1 activating other Rho GTPases exists, this data suggests that GEF-H1 has the 
ability to differentially regulate these Rho GTPases within the local environment. The 
regulation of c-Src trafficking has a variety of implications, particularly in disease 
progression. Thus, this regulation by GEF-H1 may be significant for formation of actin 
comets at c-Src vesicle membranes within the cell periphery, as c-Src at the periphery 
must be correctly localized and positioned at the plasma membrane for the formation of 
invasive structures, podosomes, that aid in VSMC migration during atherosclerotic 
plaque development (Zahradka et al., 2009).  
 
  At the same time, we show that RhoB at vesicle membranes can traffic 
bidirectionally along the MT network, in addition to associating c-Src vesicle 
membranes. We hypothesize that the localization of RhoB at c-Src defines the sites of 
preferred actin comet tail formation on c-Src vesicle membranes. In this scenario, RhoB 
puncta at vesicle membranes would facilitate asymmetric actin polymerization on the c-
Src vesicle membrane during MT depolymerization, providing the force necessary to 
propel c-Src vesicles at the cell periphery. Ultimately, we can infer that a disruption 
mislocalization of RhoB from c-Src vesicle membranes would specifically interfere with 
vesicular trafficking of c-Src vesicles, and the long-term effects would manifest in 
diminished or loss of c-Src signaling in cells. 
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 Additionally, we show that RhoB is activated upon MT depolymerization. We 
hypothesize that this activation of RhoB is mediated by GEF-H1 and occurs at c-Src 
vesicle membranes to facilitate actin polymerization. With this idea, inhibition of GEF-H1 
activity would lead to loss of actin comet tail formation and cessation of c-Src vesicle 
movement following MT depolymerization. Moreover, lack of the RhoB activation may 
inhibit trafficking and fusion of c-Src vesicles at the plasma membrane. Ultimately, we 
can infer that perturbations to RhoB activation may result in significant alterations in c-
Src activity both in the cytoplasm and at the plasma membrane. 
 
 Collectively, our results have highlighted a mechanism by which c-Src can be 
properly trafficked and positioned (Figure 3.4 C). This mechanism probably contributes 
to the regulation of c-Src to prevent aberrant signaling. In particular, precise spatial 
regulation of c-Src is necessary to prevent aberrant cell migration through the formation 
of invasive structures, podosomes, structures that rely on c-Src for their establishment 
and maintenance.  Our finding allows us to hypothesize an established dependence of 
c-Src localization on GEF-H1 and RhoB activation, which arises from the crosstalk 
between the MT and actin cytoskeleton. 
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Methods 
Cells 
 Immortalized human retinal pigment epithelial cells, hTert-RPE1 (Clontech), were 
maintained in DMEM/F12 with 10% fetal bovine serum (FBS) and 5% L-glutamine. Rat 
aortic vascular smooth muscle cells (A7r5) were grown in DMEM with 10% fetal calf 
serum and 5% L-glutamine. Cells were plated on fibronectin-coated glass coverslips 24 
hours before experiments. In all live cell experiments, cells were maintained on the 
microscope stage at 37°C under mineral oil for media equilibrium maintenance. 
 
Treatments 
 For MT depolymerization, cells were incubated in 2.5µg/ml nocodazole (Sigma, St. 
Louis, MO) 2 hours prior to imaging.  For RBD-RhoB pulldowns, cells were incubated in 
nocodazole for 30 minutes prior to cell lysis and incubation. 
 
Expression Constructs 
 GFP-Src has previously been described (Sandilands et al., 2004) was provided by 
Dr. Giulio Superti-Furga (EMBL, Heidelberg, Germany). GFP-GEF-H1 and GEF-GEF-
H1 1-573 (gifts from Gary Bokoch, La Jolla, CA). GEF-DN and GFP-RhoB were 
purchased from addgene (Cambridge, MA).  3x-mCherry-EMTB (gift from William 
Bement, Madison, WI) was used for MT visualization. RFP-cortactin was provided by 
Marko Kaksonen (U.C. Berkeley) and used to visualize actin comet tail formation. RPE1 
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and A7r5 cells were transfected with Fugene6 (Roche, Indianapolis, IN) according to 
manufacturer's protocols. 
 
Antibodies and Immunofluorescence Details 
 For actin comet tail identification, mouse monoclonal antibody against cortactin 
(1:1000; Upstate, Lake Placid, NY) was used. Cells were fixed (5' at 20°.) in 100% 
methanol. Alexa488-conjugated highly cross-absorbed goat anti-mouse IgG antibody 
(1:500; Molecular Probes, Invitrogen, Eugene, OR) was used as secondary antibodies.  
Confocal and live cell imaging 
 Leica TCS SP5 confocal laser scanning microscope with an HCX PL APO 100x oil 
lens NA 1.47 was used for taking confocal stacks of fixed cells. 
 
 Live cells plated on MatTek glass bottom dishes were maintained at 37°C by 
heated stage (Warner Instruments). Single plane confocal video sequences were taken 
were taken by Yokogawa QLC-100/CSU-10 spinning-disk head (Visitec assembled by 
Vashaw) attached to Nikon TE2000E microscope using CFI PLAN APO VC 100X OIL 
lens, NA 1.4 with 1.5× intermediate magnification and back-illuminated EM-CCD 
camera Cascade 512B (Photometrics) driven by IPLab software (Scanalytics). 75 mW 
488/568 Krypton-Argon laser (Melles Griot) with AOTF was used for 2-color excitation. 
Custom double dichroic mirror and filters (Chroma) in a filter wheel (Ludl) were used in 
the emission light path.  
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Western blot analysis 
 Western blotting was performed with the Protein Electrophoresis and Western 
Blotting System (Bio-Rad, Hercules, CA). For western blotting, a rabbit polyclonal 
antibody against RhoB (1:500; Cell Biolabs, San Diego, CA) was used. Nitrocellulose 
membrane was incubated with primary and then secondary antibody (LI-COR 
Bioscience, IRDye™ 800, Lincoln, NE) diluted in Odyssey Blocking Buffer with 0.2% 
Tween-20 to lower background. Odyssey Infrared Imaging System (LI-COR Bioscience, 
Lincoln, NE) was used for membrane scanning. 
 
RhoB Activation 
 Cells were stimulated for 30 minutes, washed with ice-cold PBS and lysed in in 
buffer containing 125mM Hepes, pH 7.5, 750 mM NaCL, 5% NP-40, 50mM MgCl2, 5mM 
EDTA, and 10% glycerol, supplemented with protease inhibitors. Lysates were cleared 
by centrifugation (14,000 rpm, 10min). A sample of supernatant was removed and 
lysates incubated with RBD beads for 1 hour at 4°C. Beads were washed three times 
with lysis buffer and protein cleaved by addition of 2x sample buffer. Samples were 
boiled and analyzed by Western blotting. 
 
Quantitative analyses: 
c-Src vesicle trafficking analysis 
 To analyze vesicle directionality and velocity in control cells and nocodazole-
treated cells, 5 min one-channel confocal sequences (5 sec/frame) of cells expressing 
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GFP-Src were used. Individual vesicles were manually tracked using the MTrackJ 
plugin of ImageJ by following movements of the vesicles as visualized by GFP-Src 
expression. 50 vesicles per condition (control or nocodazole-treated) were analyzed. 
Average velocity was calculated from instantaneous velocity measurements obtained 
from the MTrackJ plugin of ImageJ. Directional persistence of vesicles was quantified 
as final distance of vesicle relocation divided by total vesicle track length. 
 
Cortactin quantification 
 Leica confocal z-sections were obtained of control and nocodazole-treated cells 
stained for cortactin. Maximum intensity z-projections of three central slices were used 
for thresholding of cortactin puncta. Number of cortactin puncta under each condition 
was automatically quantified by ImageJ analysis. Similar methods were used upon 
expression of various GEF-H1 constructs. 
 
Cortactin association with c-Src vesicles 
 Cortactin association analysis of control and nocodazole-treated cells was 
restricted to 4µm2 ROIs. Cortactin association was scored 2.5 minutes after initiation of 
image acquisition. Number of cortactin-associated c-Src vesicles was visually scored 
and divided by the total number of c-Src vesicles within an ROI to determine association 
percentage. 
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Mander’s Coefficient Distribution 
 To determine the degree of overlap, the first frame of live-cell confocal imaging 
sequences in A7r5 cells was used. Images were subjected to thresholding in the JaCOP 
plugin of ImageJ and Mander’s coefficient was automatically calculated for the degree 
of overlap of GFP-RhoB and mCherry-Src. 
 
Statistical Analysis 
 Statistical significance was determined by Students t-test (two-tailed, unpaired). 
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CHAPTER IV 
 
Conclusions and Future Directions 
Conclusions 
The studies presented here contribute to a better understanding of the cell 
biological function of how RASSF1A impacts the processes of MT network organization 
and cell polarity and migration, in addition to its newly discovered role on impacting 
Golgi organization. These findings shed new light on the far-reaching consequences of 
MAP binding on the diverse processes mediated by microtubules. Biologically, this is 
important due to the fact that regulation of MT dynamics and reorganization, as well as 
Golgi organization, all contribute to proper cell migration, which is an essential process 
for embryonic development, wound healing, and cancer invasion and metastasis 
(Magdalena et al., 2003; Harris and Peifer, 2007; Prager-Khoutorsky et al., 2007). This 
study provides the first functional insight into the role of RASSF1A on interphase MTs 
and also identifies major functions of RASSF1A in Golgi organization and cell polarity. 
Additionally, we also provide mechanistic evidence of the bimodal transport of c-Src in 
vascular smooth muscle cells. While the currently hypothesized mechanisms of c-Src 
trafficking rely only one component of the cytoskeleton (MTs or actin), these findings 
resolve the long-standing debate about the true mechanism of c-Src trafficking. 
Moreover, this work highlights the cooperative nature of cytoskeletal crosstalk that cells 
employ to correctly position proteins. This positioning of c-Src is extremely important 
due to the fact that c-Src is critical for processes such as cell-cycle progression, cell 
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migration, and invasion (Sanjay et al., 2001; Kim et al., 2013; De Luca et al., 2014). 
With this study, we provide insight into the regulatory mechanism underlying c-Src 
trafficking. 
 
Chapter II addresses the cell biological functions of microtubule-associated 
protein, RASSF1A. Here, we describe the role that RASSF1A has on regulating MT 
dynamics and stability, in addition, to the role that RASSF1A plays in organizing the 
Golgi and in cell polarity. In terms of dynamics and stability, MT dynamic instability 
allows for rapid reorganization of the MT network in response to cellular cues. Lack of 
dynamicity can negatively impact processes such as cell migration and division. 
RASSF1A segmental localization to MTs not only provide local methods of stabilizing 
and protecting MTs from completely depolymerizing, but can also function as sites of 
rescue, which are necessary to alter the existing MT network. Interestingly, RASSF1A 
could also induce local bundling of MTs both at the Golgi and within the MT network to 
induce further stabilization of MTs. The localization of RASSF1A to the Golgi and 
stabilization of MTs is extremely important, as this can provide the necessary platform 
on which Golgi organization can occur and the stable MT tracks which allow for directed 
cell migration and trafficking. In examining cells that had lost RASSF1A expression, we 
can see that the Golgi has become completely dispersed and randomized throughout 
the cytoplasm, highlighting the role for stable MT subsets on which proper Golgi 
organization must occur. Additionally, we can see that re-expression of RASSF1A can 
reverse this dispersal and allow for a compact Golgi, similar to normal RASSF1A 
expressing cells. Moreover, we found that loss of RASSF1A correlated with a decrease 
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in the directional persistence of siRNA treated cells. This reduced directionality was 
similar to cell migration patterns exhibited by RASSF1A-deficient cancer cells. 
Interestingly, this loss of directionality also associated with changes in cell polarity. Cells 
that were either depleted of RASSF1A or were RASSF1A-null exhibited a more 
rounded, amorphous shape, as compared to control or RASSF1A-transfected cells.  
Based upon these studies, we draw a model whereby RASSF1A localizes segmentally 
within the MT network and also at the Golgi. These localizations allow for proper 
organization of the Golgi and alteration of the MT network that allow for the 
establishment of a polarized cell, thus, allowing for directional migration. The local 
bundling and stabilization capacity of RASSF1A also participates in establishing stable 
tracks upon which directional trafficking can occur. 
 
In Chapter III, I elucidate the exact mechanism of c-Src trafficking in vascular 
smooth muscle cells. This work stems from an observation that c-Src vesicle movement 
is not inhibited by depolymerization of MTs, in addition to discrepancies in the literature 
concerning the true nature of c-Src trafficking. Currently, conflicting work exists that 
implicates both the MT and actin cytoskeleton in properly trafficking and localizing c-Src 
Therefore, determining the mechanism of c-Src trafficking is important not only to 
resolve this discrepancy, but also because it provides the scientific community with 
druggable targets that can be used to inhibit cancer cell migration and invasion, both of 
which rely on c-Src. Elevated levels of c-Src expression can mediate the 
aforementioned processes through phosphorylation of downstream targets that allow for 
the formation of actin-based degradative structures, podosomes. Due to c-Src being 
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highly important for phosphorylation of normal and cancer-related targets, we 
hypothesized that the cell would utilize many mechanism of regulation to correctly 
localize it within the cell to prevent aberrant signaling, and that this localization would 
rely on both the MT and actin cytoskeleton. Thus far, we have determined that long-
range, bidirectional trafficking of c-Src is mediated by the MT network; however, in 
response to MT depolymerization, actin-based motility of c-Src vesicles can occur in a 
faster, but less directional manner. The formation of these actin comet tails at c-Src 
vesicle membranes seems to be dependent on the MT-regulated GEF, GEF-H1. We 
see MT depolymerization can double the amount of actin comet tails at vesicle 
membranes, however, inhibition of GEF-H1 activity significantly reduces this formation 
to levels even below non-treated controls. However, constitutive activation of GEF-H1 
can induce actin comet tail formation even in the presence of MTs, similar to levels seen 
in nocodazole treated controls. Furthermore, we also see that RhoB, a Rho GTPase 
implicated in being important for actin-mediated trafficking of c-Src, is also 
bidirectionally trafficked along MTs. Not surprisingly, we also find that RhoB localizes to 
c-Src vesicle membranes, potentially to mediate actin comet tail formation.  We further 
confirmed this molecular mechanism by examining the activation status of RhoB in 
response to MT depolymerization. Our results show that RhoB activation becomes 
significantly higher upon MT depolymerization as compared to non-treated control. 
Based upon these results, we propose a model whereby c-Src can be bidirectionally 
trafficked MTs, but in response to some cellular cue or dynamic instability, GEF-H1 is 
released from depolymerizing MTs, thus allowing it to interact with and activate RhoB at 
c-Src vesicle membranes. This activation would provide the necessary force for c-Src 
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vesicle fusion with the plasma membrane. Studies are ongoing to determine the 
functional consequence on podosome formation if we modulate or interrupt this 
molecular pathway. 
 
In sum, these studies provide a detailed analysis on the function of RASSF1A. 
Functionally, we have determined that RASSF1A is critical for proper Golgi organization 
and cell polarity, as well as proper MT dynamics. All of these functions contribute to 
cellular polarization and development of an asymmetric MT array that is required for cell 
migration. Additionally, we have identified a molecular mechanism for c-Src trafficking 
that requires the coordinated efforts of both the MT and actin network. This cytoskeletal 
crosstalk is crucial for prevention of mislocalization of c-Src and irregular signaling by c-
Src. Collectively, these two bodies of work present a mechanism whereby modulation of 
MT dynamics by MAPs, specifically RASSF1A can serve to regulate c-Src trafficking in 
cells.  
  
 Future Directions 
Determine the mechanism of RASSF1A localization to MTs 
   Our data indicates the RASSF1A utilizes a unique localization within the MT 
network that can regulate MT dynamics and organization (Arnette et al., 2014). The 
mechanistic details of how RASSF1A incorporates within the MT network are still 
unclear. Based on our studies, we know that RASSF1A is associated with MTs within 
the Golgi region, however, whether RASSF1A at the Golgi is capable of providing 
structural support by incorporating into the nascent protofilaments or forms a collar 
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around the MT as it polymerizes is an area that requires further examination. To 
address the association of RASSF1A with MTs, we will utilize live-cell imaging in 
combination with nocodazole washout experiments to examine MT nucleation at the 
Golgi. This will allow us to assess whether nascent MTs incorporate RASSF1A as the 
MT polymerizes. These nocodazole washout experiments can be performed with 2-
color live-cell imaging to image MTs and RASSF1A simultaneously. In order to 
determine if RASSF1A forms a collar around polymerized MTs, conventional electron 
microscopy and/or cry-em will be used to determine the higher order structure of 
purified RASSF1A. Additionally, it may be that RASSF1A localization may also be 
regulated by and/or induce alterations in the structure of protofilaments to increase 
RASSF1A binding affinity at specific sites. The structure of purified tubulin, 
repolymerized in the presence or absence of purified RASSF1A protein will be 
examined by electron microscopy. 
 
 
Determine RASSF1A domain responsible for MT association and bundling 
   
   Revealing the domain responsible for MT association and bundling is critical to 
understanding how RASSF1A can exert its influence on the MT network. RASSF1A is 
capable of both homo- and heterotypic interaction, both with itself and other RASSF 
family members (Ortiz-Vega et al., 2002). We have found that MT association is a key 
factor in the ability of RASSF1A to exert its function on MT dynamics and that MT 
bundling and stabilization is crucial for the formation of an organized Golgi structure and 
for cell polarity (Arnette et al., 2014), therefore, determining the protein-protein 
interaction domains may provide useful insight into how RASSF1A regulates Golgi 
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formation and cell polarity. To determine the domain responsible for MT association and 
bundling, several truncation mutations of wild-type RASSF1A protein will be combined 
with live-cell imaging techniques, as well as immunohistochemistry. Subsequently, 
analysis of MT bundling upon expression of various truncation mutations will be used to 
determine the RASSF1A domain(s) necessary to mediate association and bundling. 
 
Determine if cytoskeletal crosstalk in c-Src trafficking is an independent or 
combinatorial process 
 Our data indicate that c-Src vesicular trafficking relies on both the MT and actin 
network for proper positioning of c-Src. However, it is not clear whether these are two 
independent mechanisms that have evolutionarily converged to increase the efficiency 
of c-Src trafficking, or whether these are two redundant processes. Since we see actin 
polymerization localized to c-Src vesicle membranes in the presence of MTs, we 
hypothesize that this localization may serve to enhance c-Src vesicular trafficking along 
MTs, and in the absence of MTs, serves as a mechanism to deliver c-Src vesicles to the 
plasma membrane. To test if this is a convergent mechanism, triple-color live-cell 
imaging of cells expressing c-Src, cortactin, and a MT marker, EMTB, will be performed.  
As non-treated control cells do exhibit some actin polymerization at c-Src vesicle 
membranes, live-cell imaging of cells expressing the three aforementioned constructs 
will be used for analysis. Velocity analysis of c-Src vesicles that do exhibit actin 
polymerization in the presence of MTs will be compared to non-actin-associated 
vesicles to determine any added effects that this polymerization may have on vesicle 
delivery.  Directionality of these vesicles will also be assessed to determine if they 
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exhibit increased directional persistence as compared to their non-actin-associated 
counterparts. Analysis will be performed through manual tracking of c-Src vesicle 
utilizing ImageJ software to detect vesicle movement throughout the length of the 
imaging sequence.  
  
 
Determine the effect of GEF-H1 inhibition on cortactin association and RhoB 
activation 
 As we have demonstrated, MT depolymerization can lead to activation of RhoB 
in cells. Whether or not this activation is dependent upon the Rho GEF, GEF-H1 has yet 
to be determined. In order to further implicate GEF-H1 in this pathway, expression of 
various GEF-H1 constructs (GEF-WT, GEF-DN, GEF-CA) will be combined with 
immunohistochemistry and triple-color live cell imaging. The formation of actin comet 
tails in immunohistochemistry samples will be scored via similar methods as reported in 
(Arnette et al., 2014). In order to assess association of cortactin with c-Src vesicles after 
expression of various GEF-H1 constructs, mcherry-Src will be re-cloned into a Cy2-
fluorescent tag, and triple-color imaging will be utilized in control and nocodazole-
treatment conditions. The JaCoP plug-in of ImageJ will then be used to calculate 
cortactin association. Additionally, RhoB activation in cells expressing various GEF-H1 
constructs will be assessed via RBD-RhoB pulldown and western blotting both in the 
presence and absence of MTs. 
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Determine the functional consequence of inhibition of GEF-H1-mediated 
cytoskeletal crosstalk   
 As mentioned earlier, the c-Src serves to regulate several key processes within 
the cell. One important process that c-Src regulates is the formation of podosomes, 
actin-based degradative structures found in a variety of cell types (Berdeaux et al., 
2004; Gatesman et al., 2004; Tatin et al., 2006). Formation of these structures can have 
both detrimental and beneficial effects. For example, in osteoclasts, podosomes are 
necessary for bone resorption and remodeling (Destaing et al., 2008), but podosome 
formation can also contribute to disease by enhancing tumor cell migration (Yamaguchi 
et al., 2006) or invasion of VMSCs into atherosclerotic plaques (Mak, 2011). Our data 
indicates that the proper positioning of c-Src requires both MTs and actin for proper 
positioning, however, how this relates to c-Src function is yet to be resolved. To address 
this, we will first test the efficiency of podosome formation in the presence and absence 
of MTs. To further implicate GEF-H1 as a druggable target that may interfere with 
podosome formation, we will inhibit GEF-H1 activity through siRNA depletion or 
expression of a GEF-H1 dominant-negative construct and assess the formation of 
podosomes within these cells. We will be able to utilize podosome formation as a read-
out of whether or not c-Src mislocalization has any affect on subcellular structure 
formation. Podosome formation will be stimulated through pretreatment of cells with 
phorbol esters and cells will then be immediately fixed and stained for podosomal 
proteins, such as cortactin.  Analysis of the number of podosomes as well as their 
location of formation will be determined and assessed visually and with ImageJ software 
to quantify the percent area occupied by podosomes. Immunofluorescence studies will 
	   97	  
also be combined with biochemical assays (western blot) to determine the amount of 
activated Src under these conditions. 
 
Determine the location of c-Src activation 
 As mentioned, c-Src is normally found inactive within the perinuclear region 
(Radziwill et al., 2007; Walker et al., 2007); however, upon stimulation c-Src must be 
activated to interact with downstream effectors. Currently, the spatiotemporal activation 
of c-Src is unknown. It is reasonable to think that c-Src activation would occur within the 
perinuclear region or as c-Src is being trafficked out to the cell periphery; however, we 
assume that this sort of activation would allow for aberrant signaling as c-Src can then 
interact with a variety of perinuclear and cytoplasmic effector proteins, thus potentially 
leading to their activation. Therefore, we hypothesize that c-Src is locally activated at 
the plasma membrane to regulate c-Src activation of target effectors. In order to 
determine the precise location of c-Src activation, cells will be microinjected with a 
fluorescently labeled c-Src-specific biosensor (Gulyani et al., 2011) and imaged by 
differential interference contrast (DIC). From these live-cell image sequences, ratio 
images of non-stimulated and phorbol ester treated cells will be created. Ratio images 
correlated to biosensor activation will be created through automatic line scanning 
software. 
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